Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
85000,,3573546,CHEMBL1280026,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 0.06 ug/ml after 8 hrs by time-kill assay,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,968403,=,1,0,=,log10CFU/ml,,3.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10CFU/ml,,,3.4
85001,,3573547,CHEMBL1280025,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 0.06 ug/ml after 24 hrs by time-kill assay,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,968403,=,1,0,=,log10CFU/ml,,3.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10CFU/ml,,,3.4
85002,,3573548,CHEMBL1280024,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 0.12 ug/ml after 2 hrs by time-kill assay,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,968403,=,1,0,=,log10CFU/ml,,1.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10CFU/ml,,,1.1
85003,,3573549,CHEMBL1279792,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 0.12 ug/ml after 4 hrs by time-kill assay,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,968403,=,1,0,=,log10CFU/ml,,1.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10CFU/ml,,,1.9
85004,,3573550,CHEMBL1279791,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 0.12 ug/ml after 8 hrs by time-kill assay,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,968403,=,1,0,=,log10CFU/ml,,3.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10CFU/ml,,,3.3
85005,,5079604,CHEMBL1614670,Volume of distribution at steady state in human after iv administration,A,BAO_0003041,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1310407,=,1,1,=,Vdss,L.kg-1,0.11,CHEMBL612558,,ADMET,,,Vdss,L/kg,UO_0000197,0.11
85006,,5079813,CHEMBL1614671,Clearance in human after iv administration,A,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1310407,=,1,1,=,CL,mL.min-1.kg-1,0.2,CHEMBL612558,,ADMET,,,CL,mL/min/kg,,0.2
85007,,5080017,CHEMBL1614672,Fraction unbound in human after iv administration,A,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1310407,=,1,1,=,Fu,,0.07,CHEMBL3879801,,NON-PROTEIN TARGET,,,fu,,,0.07
85008,,5082579,CHEMBL1614674,Half life in human after iv administration,A,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1310407,=,1,1,=,T1/2,hr,6.7,CHEMBL612558,,ADMET,,,t1/2,h,UO_0000032,6.7
85009,,5103790,CHEMBL1638585,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus ATCC 33591 by microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
85010,,5103791,CHEMBL1638586,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1130 by microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
85011,,5103792,CHEMBL1638587,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1307 by microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
85012,,5103793,CHEMBL1638588,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1306 by microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
85013,,5103794,CHEMBL1638589,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 873 by microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
85014,,5103795,CHEMBL1638590,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 618 by microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
85015,,5103796,CHEMBL1638591,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 555 by microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85016,,5103797,CHEMBL1639384,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 770 by microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
85017,,5103798,CHEMBL1639385,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1287 by microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85018,,5103799,CHEMBL1639386,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1984 by microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
85019,,5103800,CHEMBL1639387,"Antimicrobial activity against vancomycin-resistant-, methicillin-resistant Staphylococcus aureus 510 by microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85020,,5103801,CHEMBL1639519,Antimicrobial activity against Streptococcus pyogenes HMC 414 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.06
85021,,5103802,CHEMBL1639520,Antimicrobial activity against Streptococcus agalactiae HMC 5 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.12
85022,,5103803,CHEMBL1639521,Antimicrobial activity against Enterococcus faecalis ATCC 29212 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.25
85023,,5103804,CHEMBL1639522,Antimicrobial activity against Enterococcus faecalis HMC 571 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.25
85024,,5103805,CHEMBL1639523,Antimicrobial activity against Enterococcus faecium HMC 588 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.12
85025,,5103806,CHEMBL1639524,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,1.5
85026,,5103807,CHEMBL1639525,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1130 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,1.4
85027,,5103808,CHEMBL1639526,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1307 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,1.1
85028,,5103809,CHEMBL1639527,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1306 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,1.8
85029,,5103810,CHEMBL1639528,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 873 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,1.2
85030,,5103811,CHEMBL1639529,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 618 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,1.7
85031,,5103812,CHEMBL1639530,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 555 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,3.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,3.4
85032,,5103813,CHEMBL1639531,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 770 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,1.6
85033,,5103814,CHEMBL1639532,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1287 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,1.2
85034,,5103815,CHEMBL1639533,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1984 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,0.9
85035,,5103816,CHEMBL1639534,"Antimicrobial activity against vancomycin-resistant-, methicillin-resistant Staphylococcus aureus 510 assessed as post-antibiotic effect at 10 times MIC pre-exposed for 1 hr by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,1.3
85036,,5103817,CHEMBL1639535,Antimicrobial activity against Streptococcus pyogenes HMC 414 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,6.1,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,PAE,hr,UO_0000032,6.1
85037,,5103818,CHEMBL1639536,Antimicrobial activity against Streptococcus agalactiae HMC 5 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.4,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,PAE,hr,UO_0000032,0.4
85038,,5103819,CHEMBL1639537,Antimicrobial activity against Enterococcus faecalis ATCC 29212 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.3,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,PAE,hr,UO_0000032,0.3
85039,,5103820,CHEMBL1639538,Antimicrobial activity against Enterococcus faecalis HMC 571 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,PAE,hr,UO_0000032,1.5
85040,,5103821,CHEMBL1639539,Antimicrobial activity against Enterococcus faecium HMC 588 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,PAE,hr,UO_0000032,1.2
85041,,5103822,CHEMBL1639540,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,0.3
85042,,5103823,CHEMBL1639541,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1130 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,0.0
85043,,5103824,CHEMBL1639542,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1307 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,1.0
85044,,5103825,CHEMBL1639543,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1306 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,0.7
85045,,5103826,CHEMBL1639544,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 873 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,0.0
85046,,5103827,CHEMBL1639545,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 618 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,0.3
85047,,5103828,CHEMBL1639546,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 555 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,0.3
85048,,5103829,CHEMBL1639547,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 770 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,0.7
85049,,5103830,CHEMBL1639548,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1287 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,0.0
85050,,5103831,CHEMBL1639549,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1984 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,1.0
85051,,5103832,CHEMBL1639550,"Antimicrobial activity against vancomycin-resistant-, methicillin-resistant Staphylococcus aureus 510 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,1.9
85052,,5103833,CHEMBL1639676,Antimicrobial activity against Streptococcus pyogenes HMC 414 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,PAE,hr,UO_0000032,0.0
85053,,5103834,CHEMBL1639677,Antimicrobial activity against Streptococcus agalactiae HMC 5 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.2,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,PAE,hr,UO_0000032,0.2
85054,,5103835,CHEMBL1639678,Antimicrobial activity against Enterococcus faecalis ATCC 29212 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.7,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,PAE,hr,UO_0000032,0.7
85055,,5103836,CHEMBL1639679,Antimicrobial activity against Enterococcus faecalis HMC 571 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.1,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,PAE,hr,UO_0000032,0.1
85056,,5103837,CHEMBL1639680,Antimicrobial activity against Enterococcus faecium HMC 588 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,PAE,hr,UO_0000032,1.2
85057,,5103838,CHEMBL1639681,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,7.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,7.7
85058,,5103839,CHEMBL1639682,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1130 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,5.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,5.4
85059,,5103840,CHEMBL1639683,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1307 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,6.0
85060,,5103841,CHEMBL1639684,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1306 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,2.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,2.9
85061,,5103842,CHEMBL1639685,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 873 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,5.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,5.7
85062,,5103843,CHEMBL1639686,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 618 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,5.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,5.7
85063,,5103844,CHEMBL1639687,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 555 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,5.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,5.9
85064,,5103845,CHEMBL1639688,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 770 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,3.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,3.8
85065,,5103846,CHEMBL1640444,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1287 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,5.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,5.1
85066,,5103847,CHEMBL1640445,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1984 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,6.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,6.8
85067,,5103848,CHEMBL1640446,"Antimicrobial activity against vancomycin-resistant-, methicillin-resistant Staphylococcus aureus 510 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,5.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,5.6
85068,,5103849,CHEMBL1640447,Antimicrobial activity against Streptococcus pyogenes HMC 414 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,8.7,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,PAE,hr,UO_0000032,8.7
85069,,5103850,CHEMBL1640448,Antimicrobial activity against Streptococcus agalactiae HMC 5 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.8,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,PAE,hr,UO_0000032,0.8
85070,,5103851,CHEMBL1640449,Antimicrobial activity against Enterococcus faecalis ATCC 29212 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,5.3,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,PAE,hr,UO_0000032,5.3
85071,,5103852,CHEMBL1640563,Antimicrobial activity against Enterococcus faecalis HMC 571 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,3.9,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,PAE,hr,UO_0000032,3.9
85072,,5103853,CHEMBL1640564,Antimicrobial activity against Enterococcus faecium HMC 588 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.9,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,PAE,hr,UO_0000032,1.9
85073,,5103854,CHEMBL1640565,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,1.4
85074,,5103855,CHEMBL1640566,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1130 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,2.0
85075,,5103856,CHEMBL1640567,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1307 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,2.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,2.6
85076,,5103857,CHEMBL1640568,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1306 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,5.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,5.1
85077,,5103858,CHEMBL1640569,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 873 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,0.5
85078,,5103859,CHEMBL1640570,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 618 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,1.5
85079,,5103860,CHEMBL1640571,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 555 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,1.7
85080,,5103861,CHEMBL1640572,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 770 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,0.8
85081,,5103862,CHEMBL1640573,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1287 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,0.4
85082,,5103863,CHEMBL1640574,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1984 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,2.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,2.6
85083,,5103864,CHEMBL1640575,"Antimicrobial activity against vancomycin-resistant-, methicillin-resistant Staphylococcus aureus 510 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,2.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,2.3
85084,,5103865,CHEMBL1640576,Antimicrobial activity against Streptococcus pyogenes HMC 414 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,PAE,hr,UO_0000032,0.0
85085,,5103866,CHEMBL1640577,Antimicrobial activity against Streptococcus agalactiae HMC 5 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,2.1,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,PAE,hr,UO_0000032,2.1
85086,,5103867,CHEMBL1640578,Antimicrobial activity against Enterococcus faecalis ATCC 29212 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,PAE,hr,UO_0000032,2.0
85087,,5103868,CHEMBL1640579,Antimicrobial activity against Enterococcus faecalis HMC 571 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,2.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,PAE,hr,UO_0000032,2.6
85088,,5103869,CHEMBL1640580,Antimicrobial activity against Enterococcus faecium HMC 588 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,7.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,PAE,hr,UO_0000032,7.2
85089,,5103870,CHEMBL1640581,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,10.0
85090,,5103871,CHEMBL1640582,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1130 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,10.0
85091,,5103872,CHEMBL1640583,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1307 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,10.5
85092,,5103873,CHEMBL1640584,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1306 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,5.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,5.4
85093,,5103874,CHEMBL1640585,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 873 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,8.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,8.3
85094,,5103875,CHEMBL1640586,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 618 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,8.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,8.3
85095,,5103876,CHEMBL1640587,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 555 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,4.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,4.8
85096,,5103877,CHEMBL1640588,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 770 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,6.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,6.3
85097,,5103878,CHEMBL1640589,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1287 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,8.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,8.6
85098,,5103879,CHEMBL1640590,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1984 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,10.0
85099,,5103880,CHEMBL1640591,"Antimicrobial activity against vancomycin-resistant-, methicillin-resistant Staphylococcus aureus 510 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,6.0
85100,,5103881,CHEMBL1640755,Antimicrobial activity against Streptococcus pyogenes HMC 414 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.7,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,PAE,hr,UO_0000032,10.7
85101,,5103882,CHEMBL1640756,Antimicrobial activity against Streptococcus agalactiae HMC 5 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,4.7,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,PAE,hr,UO_0000032,4.7
85102,,5103883,CHEMBL1640757,Antimicrobial activity against Enterococcus faecalis ATCC 29212 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.7,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,PAE,hr,UO_0000032,10.7
85103,,5103884,CHEMBL1640758,Antimicrobial activity against Enterococcus faecalis HMC 571 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,7.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,PAE,hr,UO_0000032,7.2
85104,,5103885,CHEMBL1640759,Antimicrobial activity against Enterococcus faecium HMC 588 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,8.9,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,PAE,hr,UO_0000032,8.9
85105,,5103886,CHEMBL1640760,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,2.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,2.3
85106,,5103887,CHEMBL1640761,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1130 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,6.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,6.5
85107,,5103888,CHEMBL1640762,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1307 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,6.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,6.3
85108,,5103889,CHEMBL1640763,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1306 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,6.0
85109,,5103890,CHEMBL1640764,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 873 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,1.0
85110,,5103891,CHEMBL1638642,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 618 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,2.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,2.3
85111,,5103892,CHEMBL1638643,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 555 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,4.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,4.3
85112,,5103893,CHEMBL1638644,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 770 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,0.8
85113,,5103894,CHEMBL1638645,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1287 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,0.8
85114,,5103895,CHEMBL1638646,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1984 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,10.0
85115,,5103896,CHEMBL1638647,"Antimicrobial activity against vancomycin-resistant-, methicillin-resistant Staphylococcus aureus 510 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,3.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,3.6
85116,,5103897,CHEMBL1638648,Antimicrobial activity against Streptococcus pyogenes HMC 414 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,0.4,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,PAE,hr,UO_0000032,0.4
85117,,5103898,CHEMBL1638649,Antimicrobial activity against Streptococcus agalactiae HMC 5 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.7,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,PAE,hr,UO_0000032,10.7
85118,,5103899,CHEMBL1638783,Antimicrobial activity against Enterococcus faecalis ATCC 29212 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,3.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,PAE,hr,UO_0000032,3.6
85119,,5103900,CHEMBL1638784,Antimicrobial activity against Enterococcus faecalis HMC 571 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,9.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,PAE,hr,UO_0000032,9.6
85120,,5103901,CHEMBL1638785,Antimicrobial activity against Enterococcus faecium HMC 588 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,8.8,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,PAE,hr,UO_0000032,8.8
85121,,5103902,CHEMBL1638786,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,10.0
85122,,5103903,CHEMBL1638787,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1130 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,10.0
85123,,5103904,CHEMBL1638788,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1307 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,10.5
85124,,5103905,CHEMBL1638789,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1306 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,10.6
85125,,5103906,CHEMBL1638790,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 873 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,6.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,6.7
85126,,5103907,CHEMBL1638791,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 618 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,10.3
85127,,5103908,CHEMBL1638792,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 555 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,10.3
85128,,5103909,CHEMBL1638793,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 770 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,9.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,9.6
85129,,5103910,CHEMBL1638794,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1287 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,10.0
85130,,5103911,CHEMBL1638795,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1984 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,10.0
85131,,5103912,CHEMBL1638796,"Antimicrobial activity against vancomycin-resistant-, methicillin-resistant Staphylococcus aureus 510 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,8.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,8.1
85132,,5103913,CHEMBL1638797,Antimicrobial activity against Streptococcus pyogenes HMC 414 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.7,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,PAE,hr,UO_0000032,10.7
85133,,5103914,CHEMBL1638798,Antimicrobial activity against Streptococcus agalactiae HMC 5 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.7,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,PAE,hr,UO_0000032,10.7
85134,,5103915,CHEMBL1638799,Antimicrobial activity against Enterococcus faecalis ATCC 29212 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.7,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,PAE,hr,UO_0000032,10.7
85135,,5103916,CHEMBL1638800,Antimicrobial activity against Enterococcus faecalis HMC 571 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,PAE,hr,UO_0000032,10.6
85136,,5103917,CHEMBL1638801,Antimicrobial activity against Enterococcus faecium HMC 588 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,PAE,hr,10.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,PAE,hr,UO_0000032,10.0
85137,,5150717,CHEMBL1664925,Antimicrobial activity against Staphylococcus aureus P1 by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649486,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326717,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
85138,,5150718,CHEMBL1664925,Antimicrobial activity against Staphylococcus aureus P1 by macrodilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649486,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326717,=,1,0,=,MBC,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,1.0
85139,,5150723,CHEMBL1664922,"Antimicrobial activity against Staphylococcus aureus P1 infected in New Zealand rabbit assessed as decrease in catheter bacterial colonization rate at 15 mg/kg, iv (Rvb = 100%)",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649486,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1326717,=,1,0,=,Activity,%,39.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,39.0
85140,,5150724,CHEMBL1664918,"Antimicrobial activity against Staphylococcus aureus P1 infected in New Zealand rabbit assessed as decrease in catheter related infection rate at 15 mg/kg, iv (Rvb = 100%)",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649486,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1326717,=,1,0,=,Activity,%,35.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,35.0
85141,,5150725,CHEMBL1664921,"Antimicrobial activity against Staphylococcus aureus P1 infected in New Zealand rabbit assessed as decrease in catheter bacterial colonization rate at 30 mg/kg, iv (Rvb = 100%)",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649486,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1326717,=,1,0,=,Activity,%,11.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,11.0
85142,,5150726,CHEMBL1664917,"Antimicrobial activity against Staphylococcus aureus P1 infected in New Zealand rabbit assessed as decrease in catheter related infection rate at 30 mg/kg, iv (Rvb = 100%)",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649486,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1326717,=,1,0,=,Activity,%,9.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,9.0
85143,,5150727,CHEMBL1664920,"Antimicrobial activity against Staphylococcus aureus P1 infected in New Zealand rabbit assessed as decrease in catheter bacterial colonization rate at 45 mg/kg, iv (Rvb = 100%)",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649486,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1326717,=,1,0,=,Activity,%,11.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,11.0
85144,,5150728,CHEMBL1664924,"Antimicrobial activity against Staphylococcus aureus P1 infected in New Zealand rabbit assessed as decrease in catheter related infection rate at 45 mg/kg, iv (Rvb = 100%)",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649486,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1326717,=,1,0,=,Activity,%,11.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,11.0
85145,,5163081,CHEMBL1665289,Antibacterial activity against slime-negative Staphylococcus epidermidis M7 after 24 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
85146,,5163084,CHEMBL1665292,Antibacterial activity against Staphylococcus epidermidis RP62A after 24 hrs by CLSI method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
85147,,5163087,CHEMBL1665295,Antibacterial activity against Staphylococcus aureus ATCC 35556 after 24 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
85148,,5163090,CHEMBL1665298,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.25
85149,,5163093,CHEMBL1665301,Antibacterial activity against methicillin-susceptible Staphylococcus aureus L2 after 24 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
85150,,5163096,CHEMBL1665304,Antibacterial activity against methicillin-resistant Staphylococcus aureus L32 after 24 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
85151,,5163099,CHEMBL1665307,Antibacterial activity against methicillin-resistant Staphylococcus aureus L83 after 24 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
85152,,5163102,CHEMBL1665289,Antibacterial activity against slime-negative Staphylococcus epidermidis M7 after 24 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,MBC,ug ml-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC,ug ml-1,UO_0000274,0.125
85153,,5163103,CHEMBL1665292,Antibacterial activity against Staphylococcus epidermidis RP62A after 24 hrs by CLSI method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,MBC,ug ml-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC,ug ml-1,UO_0000274,0.125
85154,,5163104,CHEMBL1665295,Antibacterial activity against Staphylococcus aureus ATCC 35556 after 24 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.25
85155,,5163105,CHEMBL1665298,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,MBC,ug ml-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MBC,ug ml-1,UO_0000274,1.0
85156,,5163106,CHEMBL1665301,Antibacterial activity against methicillin-susceptible Staphylococcus aureus L2 after 24 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,MBC,ug ml-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.125
85157,,5163107,CHEMBL1665304,Antibacterial activity against methicillin-resistant Staphylococcus aureus L32 after 24 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,MBC,ug ml-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.125
85158,,5163108,CHEMBL1665307,Antibacterial activity against methicillin-resistant Staphylococcus aureus L83 after 24 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,MBC,ug ml-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.125
85159,,5163117,CHEMBL1665288,Antibacterial activity against methicillin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
85160,,5163571,CHEMBL1666226,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 494 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326814,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
85161,,5163572,CHEMBL1666362,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 1199 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326814,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
85162,,5163573,CHEMBL1666363,Antimicrobial activity against heteroresistant glycopeptide-intermediate Staphylococcus aureus 1629 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326814,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
85163,,5163574,CHEMBL1666364,Antimicrobial activity against glycopeptide-intermediate Staphylococcus aureus NJ992 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326814,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85164,Active,5163591,CHEMBL1653109,Antibacterial activity against heteroresistant glycopeptide-intermediate Staphylococcus aureus 1629 assessed as decrease in bacterial load in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg administered daily after 64 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1326814,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85165,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5163592,CHEMBL1666225,Cmax in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg for every 12 hrs,A,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/Nanomolar,1326814,=,1,1,=,Cmax,nM,50180.56,CHEMBL612558,,ADMET,,,Cmax,ug ml-1,UO_0000065,88.1
85166,,5163594,CHEMBL1653091,Half life in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg for every 12 hrs,A,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,1326814,=,1,1,=,T1/2,hr,9.1,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,9.1
85167,,5163595,CHEMBL1653092,AUC (0 to 24 hrs) in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg for every 12 hrs,A,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1326814,=,1,1,=,AUC,ng.hr.mL-1,968800.0,CHEMBL612558,,ADMET,,,AUC,ug/ml.hr,,968.8
85168,Active,5163608,CHEMBL1653110,Antibacterial activity against glycopeptide-intermediate Staphylococcus aureus NJ992 assessed as decrease in bacterial load in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg administered daily after 62 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1326814,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85169,Not Active,5163609,CHEMBL1653111,Antibacterial activity against methicillin-resistant Staphylococcus aureus 494 assessed as decrease in bacterial load in in vitro pharmacokinetic/pharmacodynamic model at 1 g for every 12 hrs administered daily after 96 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1326814,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85170,Not Active,5163610,CHEMBL1653112,Antibacterial activity against methicillin-susceptible Staphylococcus aureus 1199 assessed as decrease in bacterial load in in vitro pharmacokinetic/pharmacodynamic model at 1 g for every 12 hrs administered daily after 96 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1326814,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85171,Not Active,5163611,CHEMBL1653113,Antibacterial activity against heteroresistant glycopeptide-intermediate Staphylococcus aureus 1629 assessed as decrease in bacterial load in in vitro pharmacokinetic/pharmacodynamic model at 1 g for every 12 hrs administered daily after 96 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1326814,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85172,Not Active,5163612,CHEMBL1653114,Antibacterial activity against glycopeptide-intermediate Staphylococcus aureus NJ992 assessed as decrease in bacterial load in in vitro pharmacokinetic/pharmacodynamic model at 1 g for every 12 hrs administered daily after 96 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1326814,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85173,,5181358,CHEMBL1667103,Antibacterial activity against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
85174,,5181359,CHEMBL1667105,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as induction of bacterial membrane depolarization at 32 ug/ml by flow cytometry,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,Activity,%,77.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,77.0
85175,,5181360,CHEMBL1667104,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization by flow cytometry,F,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,=,1,1,=,IC50,ug.mL-1,3.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,3.6
85176,Dose-dependent effect,5181365,CHEMBL1667104,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization by flow cytometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1327105,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85177,,5181367,CHEMBL1667109,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus ATCC 700699,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85178,,5181368,CHEMBL1667101,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85179,,5181369,CHEMBL1667110,Antibacterial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus ATCC 700698,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85180,,5181370,CHEMBL1667111,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus aureus MED2034,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85181,,5181372,CHEMBL1667106,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus ATCC 700699 assessed as induction of bacterial membrane depolarization at 32 ug/ml by flow cytometry,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,Activity,%,61.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,61.0
85182,,5181373,CHEMBL1667107,Antibacterial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus ATCC 700698 assessed as induction of bacterial membrane depolarization at 32 ug/ml by flow cytometry,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,Activity,%,78.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,78.0
85183,,5181374,CHEMBL1667108,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus aureus MED2034 assessed as induction of bacterial membrane depolarization at 32 ug/ml by flow cytometry,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,Activity,%,77.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,77.0
85184,,5181375,CHEMBL1667112,Antibacterial activity against Staphylococcus aureus in presence of 0.05 mM D-Ala-D-Ala,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85185,,5181376,CHEMBL1667113,Antibacterial activity against Staphylococcus aureus in presence of 0.5 mM D-Ala-D-Ala,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
85186,,5181377,CHEMBL1667114,Antibacterial activity against Staphylococcus aureus in presence of 5 mM D-Ala-D-Ala,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
85187,,5181378,CHEMBL1667102,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization at 8 ug/ml by flow cytometry,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,Activity,%,49.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,49.0
85188,,5181379,CHEMBL1667098,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization at 8 ug/ml by flow cytometry in presence of 0.05 mM D-Ala-D-Ala,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,Activity,%,33.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,33.0
85189,,5181380,CHEMBL1667099,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization at 8 ug/ml by flow cytometry in presence of 0.5 mM D-Ala-D-Ala,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,Activity,%,17.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,17.0
85190,,5181381,CHEMBL1667100,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization at 8 ug/ml by flow cytometry in presence of 5 mM D-Ala-D-Ala,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,Activity,%,7.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,7.0
85191,,5181382,CHEMBL1667115,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization at 32 ug/ml by flow cytometry,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,Activity,%,94.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,94.0
85192,,5181383,CHEMBL1667116,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization at 32 ug/ml by flow cytometry in presence of 0.05 mM D-Ala-D-Ala,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,Activity,%,68.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,68.0
85193,,5181384,CHEMBL1667117,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization at 32 ug/ml by flow cytometry in presence of 0.5 mM D-Ala-D-Ala,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,Activity,%,19.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,19.0
85194,,5181385,CHEMBL1667118,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization at 32 ug/ml by flow cytometry in presence of 5 mM D-Ala-D-Ala,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,Activity,%,14.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,14.0
85195,,5181386,CHEMBL1667119,Inhibition of bacterial cell wall precursor lipid 2 synthesis in Staphylococcus aureus assessed as induction of membrane depolarization at 32 ug/ml by flow cytometry in presence of fosfomycin,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,Activity,%,29.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,29.0
85196,,5181387,CHEMBL1667120,Inhibition of bacterial cell wall precursor lipid 2 synthesis in Staphylococcus aureus assessed as induction of membrane depolarization at 32 ug/ml by flow cytometry in presence of D-cycloserine,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,Activity,%,38.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,38.0
85197,,5181388,CHEMBL1667121,Inhibition of bacterial cell wall precursor lipid 2 synthesis in Staphylococcus aureus assessed as induction of membrane depolarization at 32 ug/ml by flow cytometry in presence of bacitracin,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,Activity,%,27.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,27.0
85198,Active,5181392,CHEMBL1667122,Antibacterial activity against Staphylococcus aureus grown in PBS assessed as induction of bacterial membrane depolarization at 2 to 32 ug/ml by flow cytometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1327105,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85199,Active,5181393,CHEMBL1667123,Antibacterial activity against Staphylococcus aureus grown in MHB medium assessed as induction of bacterial membrane depolarization at 2 to 32 ug/ml by flow cytometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1327105,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85200,,5181397,CHEMBL1667124,Binding affinity to cell membrane of Staphylococcus aureus grown in MHB medium at 8 ug/ml by scintillation counting relative to control,B,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1327105,=,1,0,=,FC,,2.8,CHEMBL2364031,Bacteria,Cell membrane,2.0,,FC,,,2.8
85201,Not Active,5181398,CHEMBL1667125,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial cell lysis at 8 to 32 ug/ml by spectrophotometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1327105,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85202,,5181400,CHEMBL1667581,Antibacterial activity against Staphylococcus aureus assessed as bacterial count at 8 to 32 ug/ml by turbidity assay,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1327105,=,1,0,=,log10CFU/ml,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,3.0
85203,Not Active,5181401,CHEMBL1667582,Antibacterial activity against Staphylococcus aureus assessed as change in cellular membrane integrity at 8 to 32 ug/ml up to 6 hrs by spectrophotometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1327105,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85204,,5214294,CHEMBL1679195,Antibacterial activity against Clostridium bolteae by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,4.0
85205,,5214300,CHEMBL1679196,Antibacterial activity against Clostridium clostridioforme by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL614760,Enterocloster clostridioformis,Enterocloster clostridioformis,1531.0,,MIC50,ug ml-1,UO_0000274,4.0
85206,,5214306,CHEMBL1679197,Antibacterial activity against Clostridium difficile by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC50,ug ml-1,UO_0000274,0.25
85207,,5214312,CHEMBL1679198,Antibacterial activity against Clostridium hathewayi by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.5
85208,,5214318,CHEMBL1679199,Antibacterial activity against Clostridium innocuum by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614761,[Clostridium] innocuum,[Clostridium] innocuum,1522.0,,MIC50,ug ml-1,UO_0000274,2.0
85209,,5214324,CHEMBL1679200,Antibacterial activity against Clostridium perfringens by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC50,ug ml-1,UO_0000274,0.12
85210,,5214330,CHEMBL1679358,Antibacterial activity against Clostridium ramosum by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614971,Thomasclavelia ramosa,Thomasclavelia ramosa,1547.0,,MIC50,ug ml-1,UO_0000274,0.25
85211,,5214336,CHEMBL1679359,Antibacterial activity against Clostridium subterminale by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85212,,5214342,CHEMBL1679360,Antibacterial activity against Clostridium bartlettii by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85213,,5214348,CHEMBL1679361,Antibacterial activity against Clostridium beijerinckii by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL5209646,Clostridium beijerinckii,Clostridium beijerinckii,1520.0,,MIC50,ug ml-1,UO_0000274,0.12
85214,,5214354,CHEMBL1679362,Antibacterial activity against Clostridium bifermentans by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL614962,Paraclostridium bifermentans,Paraclostridium bifermentans,1490.0,,MIC50,ug ml-1,UO_0000274,0.12
85215,,5214360,CHEMBL1679363,Antibacterial activity against Clostridium butyricum by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL614964,Clostridium butyricum,Clostridium butyricum,1492.0,,MIC50,ug ml-1,UO_0000274,0.12
85216,,5214366,CHEMBL1679364,Antibacterial activity against Clostridium celerecrescens by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85217,,5214372,CHEMBL1679365,Antibacterial activity against Clostridium disporicum by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85218,,5214378,CHEMBL1679366,Antibacterial activity against Clostridium glycolicum by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85219,,5214384,CHEMBL1679367,Antibacterial activity against Clostridium hypermegas by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85220,,5214390,CHEMBL1679368,Antibacterial activity against Clostridium leptum by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85221,,5214396,CHEMBL1679369,Antibacterial activity against Clostridium orbiscindens by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85222,,5214402,CHEMBL1679370,Antibacterial activity against Clostridium paraputrificum by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,MIC50,ug ml-1,UO_0000274,0.12
85223,,5214408,CHEMBL1679371,Antibacterial activity against Clostridium scindens by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85224,,5214414,CHEMBL1679372,Antibacterial activity against Clostridium sordellii by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL613072,Paeniclostridium sordellii,Paeniclostridium sordellii,1505.0,,MIC50,ug ml-1,UO_0000274,0.12
85225,,5214420,CHEMBL1679373,Antibacterial activity against Clostridium spiroforme by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85226,,5214426,CHEMBL1679374,Antibacterial activity against Clostridium sporogenes by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL614969,Clostridium sporogenes,Clostridium sporogenes,1509.0,,MIC50,ug ml-1,UO_0000274,0.12
85227,,5214432,CHEMBL1679375,Antibacterial activity against Clostridium sporosphaeroides by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85228,,5214438,CHEMBL1679376,Antibacterial activity against Clostridium tertium by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,MIC50,ug ml-1,UO_0000274,0.12
85229,,5215479,CHEMBL1679377,Antibacterial activity against Clostridium sp. by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85230,,5215511,CHEMBL1679195,Antibacterial activity against Clostridium bolteae by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,8.0
85231,,5215517,CHEMBL1679196,Antibacterial activity against Clostridium clostridioforme by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614760,Enterocloster clostridioformis,Enterocloster clostridioformis,1531.0,,MIC90,ug ml-1,UO_0000274,8.0
85232,,5215523,CHEMBL1679197,Antibacterial activity against Clostridium difficile by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC90,ug ml-1,UO_0000274,0.25
85233,,5215529,CHEMBL1679198,Antibacterial activity against Clostridium hathewayi by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1.0
85234,,5215535,CHEMBL1679199,Antibacterial activity against Clostridium innocuum by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL614761,[Clostridium] innocuum,[Clostridium] innocuum,1522.0,,MIC90,ug ml-1,UO_0000274,2.0
85235,,5215541,CHEMBL1679200,Antibacterial activity against Clostridium perfringens by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC90,ug ml-1,UO_0000274,0.25
85236,,5215547,CHEMBL1679358,Antibacterial activity against Clostridium ramosum by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614971,Thomasclavelia ramosa,Thomasclavelia ramosa,1547.0,,MIC90,ug ml-1,UO_0000274,0.25
85237,,5215553,CHEMBL1679359,Antibacterial activity against Clostridium subterminale by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC90,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.12
85238,,5215559,CHEMBL1679360,Antibacterial activity against Clostridium bartlettii by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.25
85239,,5215565,CHEMBL1679361,Antibacterial activity against Clostridium beijerinckii by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL5209646,Clostridium beijerinckii,Clostridium beijerinckii,1520.0,,MIC90,ug ml-1,UO_0000274,0.25
85240,,5215571,CHEMBL1679362,Antibacterial activity against Clostridium bifermentans by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614962,Paraclostridium bifermentans,Paraclostridium bifermentans,1490.0,,MIC90,ug ml-1,UO_0000274,0.25
85241,,5215577,CHEMBL1679363,Antibacterial activity against Clostridium butyricum by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614964,Clostridium butyricum,Clostridium butyricum,1492.0,,MIC90,ug ml-1,UO_0000274,0.25
85242,,5215583,CHEMBL1679364,Antibacterial activity against Clostridium celerecrescens by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.25
85243,,5215589,CHEMBL1679365,Antibacterial activity against Clostridium disporicum by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.25
85244,,5215595,CHEMBL1679366,Antibacterial activity against Clostridium glycolicum by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.25
85245,,5215601,CHEMBL1679367,Antibacterial activity against Clostridium hypermegas by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.25
85246,,5215607,CHEMBL1679368,Antibacterial activity against Clostridium leptum by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.25
85247,,5215613,CHEMBL1679369,Antibacterial activity against Clostridium orbiscindens by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.25
85248,,5215619,CHEMBL1679370,Antibacterial activity against Clostridium paraputrificum by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,MIC90,ug ml-1,UO_0000274,0.25
85249,,5215625,CHEMBL1679371,Antibacterial activity against Clostridium scindens by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.25
85250,,5215631,CHEMBL1679372,Antibacterial activity against Clostridium sordellii by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL613072,Paeniclostridium sordellii,Paeniclostridium sordellii,1505.0,,MIC90,ug ml-1,UO_0000274,0.25
85251,,5215637,CHEMBL1679373,Antibacterial activity against Clostridium spiroforme by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.25
85252,,5215643,CHEMBL1679374,Antibacterial activity against Clostridium sporogenes by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614969,Clostridium sporogenes,Clostridium sporogenes,1509.0,,MIC90,ug ml-1,UO_0000274,0.25
85253,,5215649,CHEMBL1679375,Antibacterial activity against Clostridium sporosphaeroides by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.25
85254,,5215655,CHEMBL1679376,Antibacterial activity against Clostridium tertium by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,MIC90,ug ml-1,UO_0000274,0.25
85255,,5215661,CHEMBL1679377,Antibacterial activity against Clostridium sp. by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.25
85256,,5215693,CHEMBL1679195,Antibacterial activity against Clostridium bolteae by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.5
85257,,5215699,CHEMBL1679196,Antibacterial activity against Clostridium clostridioforme by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614760,Enterocloster clostridioformis,Enterocloster clostridioformis,1531.0,,MIC,ug ml-1,UO_0000274,0.5
85258,,5215705,CHEMBL1679197,Antibacterial activity against Clostridium difficile by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,0.12
85259,,5215711,CHEMBL1679198,Antibacterial activity against Clostridium hathewayi by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
85260,,5215717,CHEMBL1679199,Antibacterial activity against Clostridium innocuum by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614761,[Clostridium] innocuum,[Clostridium] innocuum,1522.0,,MIC,ug ml-1,UO_0000274,1.0
85261,,5215723,CHEMBL1679200,Antibacterial activity against Clostridium perfringens by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC,ug ml-1,UO_0000274,0.12
85262,,5215729,CHEMBL1679358,Antibacterial activity against Clostridium ramosum by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614971,Thomasclavelia ramosa,Thomasclavelia ramosa,1547.0,,MIC,ug ml-1,UO_0000274,0.25
85263,,5215735,CHEMBL1679359,Antibacterial activity against Clostridium subterminale by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85264,,5215741,CHEMBL1679360,Antibacterial activity against Clostridium bartlettii by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85265,,5215747,CHEMBL1679361,Antibacterial activity against Clostridium beijerinckii by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL5209646,Clostridium beijerinckii,Clostridium beijerinckii,1520.0,,MIC,ug ml-1,UO_0000274,0.12
85266,,5215753,CHEMBL1679362,Antibacterial activity against Clostridium bifermentans by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614962,Paraclostridium bifermentans,Paraclostridium bifermentans,1490.0,,MIC,ug ml-1,UO_0000274,0.12
85267,,5215759,CHEMBL1679363,Antibacterial activity against Clostridium butyricum by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614964,Clostridium butyricum,Clostridium butyricum,1492.0,,MIC,ug ml-1,UO_0000274,0.12
85268,,5215765,CHEMBL1679364,Antibacterial activity against Clostridium celerecrescens by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85269,,5215771,CHEMBL1679365,Antibacterial activity against Clostridium disporicum by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85270,,5215777,CHEMBL1679366,Antibacterial activity against Clostridium glycolicum by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85271,,5215783,CHEMBL1679367,Antibacterial activity against Clostridium hypermegas by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85272,,5215789,CHEMBL1679368,Antibacterial activity against Clostridium leptum by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85273,,5215795,CHEMBL1679369,Antibacterial activity against Clostridium orbiscindens by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85274,,5215801,CHEMBL1679370,Antibacterial activity against Clostridium paraputrificum by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,MIC,ug ml-1,UO_0000274,0.12
85275,,5215807,CHEMBL1679371,Antibacterial activity against Clostridium scindens by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85276,,5215860,CHEMBL1677556,"Antimicrobial activity against streptomycin-resistant, vancomycin-susceptible Enterococcus faecalis BM4110 by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332181,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
85277,,5215861,CHEMBL1677557,Antimicrobial activity against Enterococcus faecalis BM4110 expressing VanA and harboring transposon tn1546 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332181,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
85278,,5215862,CHEMBL1677558,Antimicrobial activity against Enterococcus faecium ATCC 51559 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332181,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8.0
85279,,5215863,CHEMBL1677559,Antimicrobial activity against Enterococcus faecalis ATCC 51299 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332181,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
85280,,5215864,CHEMBL1677560,Antimicrobial activity against Enterococcus faecalis ATCC 51575 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332181,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
85281,Not Determined,5215880,CHEMBL1677420,Induction of VanA activity in vancomycin susceptible Enterococcus faecalis BM4110 assessed as UDP-MurNAc-tetrapeptide profile at 0.1 ug/ml by Western blotting,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1332181,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85282,,5215881,CHEMBL1677422,Induction of VanA activity in vancomycin susceptible Enterococcus faecalis BM4110 harboring Van A gene assessed as UDP-MurNAc-tetrapeptide profile at 4 ug/ml by Western blotting,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1332181,=,1,0,=,Activity,%,26.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,26.0
85283,,5215882,CHEMBL1677424,Induction of VanA activity in Enterococcus faecium ATCC 51559 expressing Van A gene assessed as UDP-MurNAc-tetrapeptide profile at 4 ug/ml by Western blotting,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1332181,=,1,0,=,Activity,%,40.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,40.0
85284,Not Determined,5215883,CHEMBL1677426,Induction of VanA activity in Enterococcus faecalis ATCC 51299 expressing Van B gene assessed as UDP-MurNAc-tetrapeptide profile at 0.1 ug/ml by Western blotting,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1332181,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85285,Not Determined,5215884,CHEMBL1677428,Induction of VanA activity in Enterococcus faecalis ATCC 51575 expressing Van B gene assessed as UDP-MurNAc-tetrapeptide profile at 0.1 ug/ml by Western blotting,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1332181,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85286,,5215885,CHEMBL1677430,Induction of VanA activity in vancomycin susceptible Enterococcus faecalis BM4110 assessed as UDP-MurNAc-pentapeptide profile at 0.1 ug/ml by Western blotting,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1332181,=,1,0,=,Activity,%,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,100.0
85287,Not Determined,5215886,CHEMBL1677432,Induction of VanA activity in vancomycin susceptible Enterococcus faecalis BM4110 harboring Van A gene assessed as UDP-MurNAc-pentapeptide profile at 4 ug/ml by Western blotting,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1332181,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85288,,5215887,CHEMBL1677434,Induction of VanA activity in Enterococcus faecium ATCC 51559 expressing Van A gene assessed as UDP-MurNAc-pentapeptide profile at 4 ug/ml by Western blotting,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1332181,=,1,0,=,Activity,%,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,8.0
85289,,5215888,CHEMBL1677436,Induction of VanA activity in Enterococcus faecalis ATCC 51299 expressing Van B gene assessed as UDP-MurNAc-pentapeptide profile at 0.1 ug/ml by Western blotting,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1332181,=,1,0,=,Activity,%,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,100.0
85290,,5215889,CHEMBL1677438,Induction of VanA activity in Enterococcus faecalis ATCC 51575 expressing Van B gene assessed as UDP-MurNAc-pentapeptide profile at 0.1 ug/ml by Western blotting,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1332181,=,1,0,=,Activity,%,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,100.0
85291,Not Determined,5215890,CHEMBL1677440,Induction of VanX activity in vancomycin susceptible Enterococcus faecalis BM4110 assessed as UDP-MurNAc-depsipeptide profile at 0.1 ug/ml by Western blotting,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1332181,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85292,,5215891,CHEMBL1677549,Induction of VanX activity in vancomycin susceptible Enterococcus faecalis BM4110 harboring Van A gene assessed as UDP-MurNAc-depsipeptide profile at 4 ug/ml by Western blotting,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1332181,=,1,0,=,Activity,%,74.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,74.0
85293,,5215892,CHEMBL1677551,Induction of VanX activity in Enterococcus faecium ATCC 51559 expressing Van A gene assessed as UDP-MurNAc-depsipeptide profile at 4 ug/ml by Western blotting,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Percent,1332181,=,1,0,=,Activity,%,52.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,52.0
85294,Not Determined,5215893,CHEMBL1677553,Induction of VanX activity in Enterococcus faecalis ATCC 51299 expressing Van B gene assessed as UDP-MurNAc-depsipeptide profile at 0.1 ug/ml by Western blotting,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1332181,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85295,Not Determined,5215894,CHEMBL1677555,Induction of VanX activity in Enterococcus faecalis ATCC 51575 expressing Van B gene assessed as UDP-MurNAc-depsipeptide profile at 0.1 ug/ml by Western blotting,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1332181,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85296,Not Active,5215899,CHEMBL1677417,Induction of VanX activity in Enterococcus faecalis ATCC 51299 expressing Van B gene at 0.3 times MIC by high-performance liquid chromatography,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1332181,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85297,Not Active,5215900,CHEMBL1677418,Induction of VanX activity in Enterococcus faecalis ATCC 51575 expressing Van B gene at 0.3 times MIC by high-performance liquid chromatography,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1332181,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85298,,5215902,CHEMBL1677561,Induction of VanX activity in Enterococcus faecalis BM4110 expressing VanA and harboring transposon tn1546 at 0.4 times MIC by Western blotting relative to uninduced control,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1332181,=,1,0,=,FC,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,FC,,,4.0
85299,,5215903,CHEMBL1677562,"Induction of D,D-dipeptidase activity in Enterococcus faecalis BM4110 expressing VanA and harboring transposon tn1546 at 0.4 times MIC by Western blotting relative to uninduced control",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1332181,=,1,0,=,FC,,6.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,FC,,,6.0
85300,,5216847,CHEMBL1679372,Antibacterial activity against Clostridium sordellii by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL613072,Paeniclostridium sordellii,Paeniclostridium sordellii,1505.0,,MIC,ug ml-1,UO_0000274,0.12
85301,,5216853,CHEMBL1679373,Antibacterial activity against Clostridium spiroforme by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85302,,5216859,CHEMBL1679374,Antibacterial activity against Clostridium sporogenes by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614969,Clostridium sporogenes,Clostridium sporogenes,1509.0,,MIC,ug ml-1,UO_0000274,0.12
85303,,5216865,CHEMBL1679375,Antibacterial activity against Clostridium sporosphaeroides by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85304,,5216871,CHEMBL1679376,Antibacterial activity against Clostridium tertium by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,MIC,ug ml-1,UO_0000274,0.12
85305,,5216877,CHEMBL1679377,Antibacterial activity against Clostridium sp. by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85306,,5216909,CHEMBL1679378,Antibacterial activity against Actinomyces naeslundii by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL614975,Actinomyces naeslundii,Actinomyces naeslundii,1655.0,,MIC50,ug ml-1,UO_0000274,0.12
85307,,5216915,CHEMBL1679379,Antibacterial activity against Bifidobacterium adolescentis by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85308,,5216921,CHEMBL1679380,Antibacterial activity against Bifidobacterium bifidum by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC50,ug ml-1,UO_0000274,0.12
85309,,5216927,CHEMBL1679381,Antibacterial activity against Bifidobacterium breve by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC50,ug ml-1,UO_0000274,0.12
85310,,5216933,CHEMBL1679382,Antibacterial activity against Bifidobacterium dentium by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85311,,5216939,CHEMBL1679383,Antibacterial activity against Bifidobacterium infantis by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85312,,5216945,CHEMBL1679384,Antibacterial activity against Bifidobacterium longum by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC50,ug ml-1,UO_0000274,0.12
85313,,5216951,CHEMBL1679385,Antibacterial activity against Bifidobacterium pseudolongum by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85314,,5216957,CHEMBL1679386,Antibacterial activity against Catenibacterium mitsuokai by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85315,,5216963,CHEMBL1679387,Antibacterial activity against Colinsella aerofaciens by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL612692,Collinsella aerofaciens,Collinsella aerofaciens,74426.0,,MIC50,ug ml-1,UO_0000274,0.12
85316,,5216969,CHEMBL1679388,Antibacterial activity against Coprobacillus cateniformis by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85317,,5216975,CHEMBL1679389,Antibacterial activity against Coriobacteriumecies by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85318,,5216981,CHEMBL1679390,Antibacterial activity against Eggerthella lenta by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL612337,Eggerthella lenta,Eggerthella lenta,84112.0,,MIC50,ug ml-1,UO_0000274,0.12
85319,,5216987,CHEMBL1679391,Antibacterial activity against Holdemania filiformis by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85320,,5216993,CHEMBL1679392,Antibacterial activity against Propionibacterium propionicus by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85321,,5216999,CHEMBL1679393,Antibacterial activity against Ruminococcus gnavus by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85322,,5217005,CHEMBL1679394,Antibacterial activity against Ruminococcus obeum by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85323,,5217011,CHEMBL1679395,Antibacterial activity against Ruminococcus albus by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85324,,5217017,CHEMBL1679396,Antibacterial activity against Ruminococcus flavefaciens by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85325,,5217023,CHEMBL1679397,Antibacterial activity against Ruminococcus luti by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85326,,5217029,CHEMBL1680088,Antibacterial activity against Ruminococcus lactaris by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85327,,5217035,CHEMBL1680089,Antibacterial activity against Ruminococcus productus by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85328,,5217041,CHEMBL1680090,Antibacterial activity against Ruminococcus torques by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85329,,5217047,CHEMBL1680091,Antibacterial activity against Ruminococcus sp. by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL613276,Ruminococcus sp.,Ruminococcus sp.,41978.0,,MIC50,ug ml-1,UO_0000274,0.12
85330,,5217053,CHEMBL1680092,Antibacterial activity against Anaerococcus prevotii by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,MIC50,ug ml-1,UO_0000274,0.12
85331,,5217059,CHEMBL1680229,Antibacterial activity against Anaerococcus tetradius by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL614747,Anaerococcus tetradius,Anaerococcus tetradius,33036.0,,MIC50,ug ml-1,UO_0000274,0.12
85332,,5217065,CHEMBL1680230,Antibacterial activity against Finegoldia magna by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,MIC50,ug ml-1,UO_0000274,0.12
85333,,5217071,CHEMBL1680231,Antibacterial activity against Peptoniphilus asaccharolyticus by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,MIC50,ug ml-1,UO_0000274,0.12
85334,,5217077,CHEMBL1680232,Antibacterial activity against Peptostreptococcus anaerobius by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC50,ug ml-1,UO_0000274,0.12
85335,,5217083,CHEMBL1680233,Antibacterial activity against Peptostreptococcus micros by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,MIC50,ug ml-1,UO_0000274,0.12
85336,,5217089,CHEMBL1680234,Antibacterial activity against Streptococcus anginosus by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
85337,,5217095,CHEMBL1680235,Antibacterial activity against Streptococcus constellatus by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC50,ug ml-1,UO_0000274,0.12
85338,,5217101,CHEMBL1680236,Antibacterial activity against Streptococcus intermedius by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC50,ug ml-1,UO_0000274,0.12
85339,,5217107,CHEMBL1680237,Antibacterial activity against Parabacteroides distasonis by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC50,ug.mL-1,64.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,MIC50,ug ml-1,UO_0000274,64.0
85340,,5217113,CHEMBL1680238,Antibacterial activity against Parabacteroides merdae by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC50,ug.mL-1,64.0,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,MIC50,ug ml-1,UO_0000274,64.0
85341,,5217119,CHEMBL1680239,Antibacterial activity against Bacteroides fragilis by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC50,ug.mL-1,64.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC50,ug ml-1,UO_0000274,64.0
85342,,5217160,CHEMBL1679378,Antibacterial activity against Actinomyces naeslundii by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL614975,Actinomyces naeslundii,Actinomyces naeslundii,1655.0,,MIC90,ug ml-1,UO_0000274,0.5
85343,,5217166,CHEMBL1679379,Antibacterial activity against Bifidobacterium adolescentis by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
85344,,5217172,CHEMBL1679380,Antibacterial activity against Bifidobacterium bifidum by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC90,ug ml-1,UO_0000274,0.5
85345,,5218215,CHEMBL1679381,Antibacterial activity against Bifidobacterium breve by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC90,ug ml-1,UO_0000274,0.5
85346,,5218221,CHEMBL1679382,Antibacterial activity against Bifidobacterium dentium by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
85347,,5218227,CHEMBL1679383,Antibacterial activity against Bifidobacterium infantis by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
85348,,5218233,CHEMBL1679384,Antibacterial activity against Bifidobacterium longum by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC90,ug ml-1,UO_0000274,0.5
85349,,5218239,CHEMBL1679385,Antibacterial activity against Bifidobacterium pseudolongum by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
85350,,5218245,CHEMBL1679386,Antibacterial activity against Catenibacterium mitsuokai by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
85351,,5218251,CHEMBL1679387,Antibacterial activity against Colinsella aerofaciens by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612692,Collinsella aerofaciens,Collinsella aerofaciens,74426.0,,MIC90,ug ml-1,UO_0000274,0.5
85352,,5218257,CHEMBL1679388,Antibacterial activity against Coprobacillus cateniformis by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
85353,,5218263,CHEMBL1679389,Antibacterial activity against Coriobacteriumecies by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
85354,,5218269,CHEMBL1679390,Antibacterial activity against Eggerthella lenta by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612337,Eggerthella lenta,Eggerthella lenta,84112.0,,MIC90,ug ml-1,UO_0000274,0.5
85355,,5218275,CHEMBL1679391,Antibacterial activity against Holdemania filiformis by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
85356,,5218281,CHEMBL1679392,Antibacterial activity against Propionibacterium propionicus by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
85357,,5218287,CHEMBL1679393,Antibacterial activity against Ruminococcus gnavus by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC90,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.12
85358,,5218293,CHEMBL1679394,Antibacterial activity against Ruminococcus obeum by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC90,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.12
85359,,5218299,CHEMBL1679395,Antibacterial activity against Ruminococcus albus by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC90,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.12
85360,,5218305,CHEMBL1679396,Antibacterial activity against Ruminococcus flavefaciens by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC90,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.12
85361,,5218311,CHEMBL1679397,Antibacterial activity against Ruminococcus luti by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC90,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.12
85362,,5218317,CHEMBL1680088,Antibacterial activity against Ruminococcus lactaris by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC90,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.12
85363,,5218323,CHEMBL1680089,Antibacterial activity against Ruminococcus productus by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC90,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.12
85364,,5218329,CHEMBL1680090,Antibacterial activity against Ruminococcus torques by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC90,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.12
85365,,5218335,CHEMBL1680091,Antibacterial activity against Ruminococcus sp. by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL613276,Ruminococcus sp.,Ruminococcus sp.,41978.0,,MIC90,ug ml-1,UO_0000274,0.25
85366,,5218341,CHEMBL1680092,Antibacterial activity against Anaerococcus prevotii by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,MIC90,ug ml-1,UO_0000274,0.25
85367,,5218347,CHEMBL1680229,Antibacterial activity against Anaerococcus tetradius by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614747,Anaerococcus tetradius,Anaerococcus tetradius,33036.0,,MIC90,ug ml-1,UO_0000274,0.25
85368,,5218353,CHEMBL1680230,Antibacterial activity against Finegoldia magna by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,MIC90,ug ml-1,UO_0000274,0.25
85369,,5218359,CHEMBL1680231,Antibacterial activity against Peptoniphilus asaccharolyticus by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,MIC90,ug ml-1,UO_0000274,0.25
85370,,5218365,CHEMBL1680232,Antibacterial activity against Peptostreptococcus anaerobius by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC90,ug ml-1,UO_0000274,0.25
85371,,5218371,CHEMBL1680233,Antibacterial activity against Peptostreptococcus micros by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,MIC90,ug ml-1,UO_0000274,0.25
85372,,5218377,CHEMBL1680234,Antibacterial activity against Streptococcus anginosus by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC90,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.12
85373,,5218383,CHEMBL1680235,Antibacterial activity against Streptococcus constellatus by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC90,ug.mL-1,0.12,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC90,ug ml-1,UO_0000274,0.12
85374,,5218389,CHEMBL1680236,Antibacterial activity against Streptococcus intermedius by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC90,ug.mL-1,0.12,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC90,ug ml-1,UO_0000274,0.12
85375,,5218395,CHEMBL1680237,Antibacterial activity against Parabacteroides distasonis by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,MIC90,ug ml-1,UO_0000274,64.0
85376,,5218401,CHEMBL1680238,Antibacterial activity against Parabacteroides merdae by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,MIC90,ug ml-1,UO_0000274,64.0
85377,,5218407,CHEMBL1680239,Antibacterial activity against Bacteroides fragilis by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC90,ug ml-1,UO_0000274,64.0
85378,,5218448,CHEMBL1679378,Antibacterial activity against Actinomyces naeslundii by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614975,Actinomyces naeslundii,Actinomyces naeslundii,1655.0,,MIC,ug ml-1,UO_0000274,0.12
85379,,5218454,CHEMBL1679379,Antibacterial activity against Bifidobacterium adolescentis by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85380,,5218460,CHEMBL1679380,Antibacterial activity against Bifidobacterium bifidum by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,0.12
85381,,5218466,CHEMBL1679381,Antibacterial activity against Bifidobacterium breve by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,0.12
85382,,5218472,CHEMBL1679382,Antibacterial activity against Bifidobacterium dentium by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85383,,5218478,CHEMBL1679383,Antibacterial activity against Bifidobacterium infantis by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85384,,5218484,CHEMBL1679384,Antibacterial activity against Bifidobacterium longum by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,0.12
85385,,5218490,CHEMBL1679385,Antibacterial activity against Bifidobacterium pseudolongum by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85386,,5218496,CHEMBL1679386,Antibacterial activity against Catenibacterium mitsuokai by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85387,,5218502,CHEMBL1679387,Antibacterial activity against Colinsella aerofaciens by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612692,Collinsella aerofaciens,Collinsella aerofaciens,74426.0,,MIC,ug ml-1,UO_0000274,0.12
85388,,5218508,CHEMBL1679388,Antibacterial activity against Coprobacillus cateniformis by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85389,,5218514,CHEMBL1679389,Antibacterial activity against Coriobacteriumecies by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85390,,5218520,CHEMBL1679390,Antibacterial activity against Eggerthella lenta by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612337,Eggerthella lenta,Eggerthella lenta,84112.0,,MIC,ug ml-1,UO_0000274,0.12
85391,,5218526,CHEMBL1679391,Antibacterial activity against Holdemania filiformis by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85392,,5218532,CHEMBL1679392,Antibacterial activity against Propionibacterium propionicus by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85393,,5218538,CHEMBL1679393,Antibacterial activity against Ruminococcus gnavus by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85394,,5218544,CHEMBL1679394,Antibacterial activity against Ruminococcus obeum by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85395,,5219605,CHEMBL1679395,Antibacterial activity against Ruminococcus albus by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85396,,5219611,CHEMBL1679396,Antibacterial activity against Ruminococcus flavefaciens by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85397,,5219617,CHEMBL1679397,Antibacterial activity against Ruminococcus luti by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85398,,5219623,CHEMBL1680088,Antibacterial activity against Ruminococcus lactaris by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85399,,5219629,CHEMBL1680089,Antibacterial activity against Ruminococcus productus by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85400,,5219635,CHEMBL1680090,Antibacterial activity against Ruminococcus torques by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85401,,5219641,CHEMBL1680091,Antibacterial activity against Ruminococcus sp. by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL613276,Ruminococcus sp.,Ruminococcus sp.,41978.0,,MIC,ug ml-1,UO_0000274,0.12
85402,,5219647,CHEMBL1680092,Antibacterial activity against Anaerococcus prevotii by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,MIC,ug ml-1,UO_0000274,0.12
85403,,5219653,CHEMBL1680229,Antibacterial activity against Anaerococcus tetradius by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614747,Anaerococcus tetradius,Anaerococcus tetradius,33036.0,,MIC,ug ml-1,UO_0000274,0.12
85404,,5219659,CHEMBL1680230,Antibacterial activity against Finegoldia magna by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,MIC,ug ml-1,UO_0000274,0.12
85405,,5219665,CHEMBL1680231,Antibacterial activity against Peptoniphilus asaccharolyticus by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,MIC,ug ml-1,UO_0000274,0.12
85406,,5219671,CHEMBL1680232,Antibacterial activity against Peptostreptococcus anaerobius by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC,ug ml-1,UO_0000274,0.12
85407,,5219677,CHEMBL1680233,Antibacterial activity against Peptostreptococcus micros by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,MIC,ug ml-1,UO_0000274,0.12
85408,,5219683,CHEMBL1680234,Antibacterial activity against Streptococcus anginosus by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85409,,5219689,CHEMBL1680235,Antibacterial activity against Streptococcus constellatus by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC,ug ml-1,UO_0000274,0.12
85410,,5219695,CHEMBL1680236,Antibacterial activity against Streptococcus intermedius by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC,ug ml-1,UO_0000274,0.12
85411,,5219701,CHEMBL1680237,Antibacterial activity against Parabacteroides distasonis by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,MIC,ug ml-1,UO_0000274,64.0
85412,,5219707,CHEMBL1680238,Antibacterial activity against Parabacteroides merdae by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,MIC,ug ml-1,UO_0000274,64.0
85413,,5219713,CHEMBL1680239,Antibacterial activity against Bacteroides fragilis by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC,ug ml-1,UO_0000274,64.0
85414,,5219754,CHEMBL1680240,Antibacterial activity against Bacteroides ovatus by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC50,ug.mL-1,64.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,MIC50,ug ml-1,UO_0000274,64.0
85415,,5219760,CHEMBL1680241,Antibacterial activity against Bacteroides thetaiotaomicron by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC50,ug.mL-1,64.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC50,ug ml-1,UO_0000274,64.0
85416,,5219766,CHEMBL1680242,Antibacterial activity against Bacteroides vulgatus by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC50,ug.mL-1,64.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,MIC50,ug ml-1,UO_0000274,64.0
85417,,5219772,CHEMBL1680243,Antibacterial activity against Bacteroides splanchnicus by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC50,ug.mL-1,64.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,64.0
85418,,5219778,CHEMBL1680244,Antibacterial activity against Bilophila wadsworthia by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC50,ug.mL-1,64.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,64.0
85419,,5219784,CHEMBL1680245,Antibacterial activity against Fusobacterium mortiferum by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC50,ug.mL-1,64.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,MIC50,ug ml-1,UO_0000274,64.0
85420,,5219790,CHEMBL1680246,Antibacterial activity against Fusobacterium varium by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC50,ug.mL-1,64.0,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,MIC50,ug ml-1,UO_0000274,64.0
85421,,5219796,CHEMBL1680247,Antibacterial activity against Prevotella bivia by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,MIC50,ug ml-1,UO_0000274,8.0
85422,,5219802,CHEMBL1680248,Antibacterial activity against Prevotella buccae by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,MIC50,ug ml-1,UO_0000274,8.0
85423,,5219808,CHEMBL1680249,Antibacterial activity against Prevotella corporis by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL615061,Prevotella corporis,Prevotella corporis,28128.0,,MIC50,ug ml-1,UO_0000274,8.0
85424,,5219814,CHEMBL1680250,Antibacterial activity against Prevotella P denticola by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL615062,Prevotella denticola,Prevotella denticola,28129.0,,MIC50,ug ml-1,UO_0000274,8.0
85425,,5219820,CHEMBL1680251,Antibacterial activity against Prevotella P disiens by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL612235,Prevotella disiens,Prevotella disiens,28130.0,,MIC50,ug ml-1,UO_0000274,8.0
85426,,5219826,CHEMBL1680252,Antibacterial activity against Prevotella P intermedia by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC50,ug ml-1,UO_0000274,8.0
85427,,5219832,CHEMBL1680253,Antibacterial activity against Prevotella intermedia by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC50,ug ml-1,UO_0000274,8.0
85428,,5219838,CHEMBL1680254,Antibacterial activity against Prevotella nigrescens by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL615063,Prevotella nigrescens,Prevotella nigrescens,28133.0,,MIC50,ug ml-1,UO_0000274,8.0
85429,,5219844,CHEMBL1680255,Antibacterial activity against Prevotella loescheii by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614607,Hoylesella loescheii,Hoylesella loescheii,840.0,,MIC50,ug ml-1,UO_0000274,8.0
85430,,5219850,CHEMBL1680256,Antibacterial activity against Prevotella melaninogenica by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,MIC50,ug ml-1,UO_0000274,8.0
85431,,5219856,CHEMBL1680257,Antibacterial activity against Prevotella oralis by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL612687,Hoylesella oralis,Hoylesella oralis,28134.0,,MIC50,ug ml-1,UO_0000274,8.0
85432,,5219862,CHEMBL1680258,Antibacterial activity against Prevotella oris by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,8.0
85433,,5219868,CHEMBL1680259,Antibacterial activity against Sutterella wadsworthensis by CLSI M11-A6 agar dilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC50,ug.mL-1,64.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,64.0
85434,,5219893,CHEMBL1680240,Antibacterial activity against Bacteroides ovatus by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,MIC90,ug ml-1,UO_0000274,64.0
85435,,5219899,CHEMBL1680241,Antibacterial activity against Bacteroides thetaiotaomicron by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC90,ug ml-1,UO_0000274,64.0
85436,,5219905,CHEMBL1680242,Antibacterial activity against Bacteroides vulgatus by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,MIC90,ug ml-1,UO_0000274,64.0
85437,,5219911,CHEMBL1680243,Antibacterial activity against Bacteroides splanchnicus by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,64.0
85438,,5219917,CHEMBL1680244,Antibacterial activity against Bilophila wadsworthia by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,64.0
85439,,5219923,CHEMBL1680245,Antibacterial activity against Fusobacterium mortiferum by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,MIC90,ug ml-1,UO_0000274,64.0
85440,,5219929,CHEMBL1680246,Antibacterial activity against Fusobacterium varium by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,MIC90,ug ml-1,UO_0000274,64.0
85441,,5219935,CHEMBL1680247,Antibacterial activity against Prevotella bivia by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,MIC90,ug ml-1,UO_0000274,64.0
85442,,5221011,CHEMBL1680248,Antibacterial activity against Prevotella buccae by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,MIC90,ug ml-1,UO_0000274,64.0
85443,,5221017,CHEMBL1680249,Antibacterial activity against Prevotella corporis by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL615061,Prevotella corporis,Prevotella corporis,28128.0,,MIC90,ug ml-1,UO_0000274,64.0
85444,,5221023,CHEMBL1680250,Antibacterial activity against Prevotella P denticola by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL615062,Prevotella denticola,Prevotella denticola,28129.0,,MIC90,ug ml-1,UO_0000274,64.0
85445,,5221029,CHEMBL1680251,Antibacterial activity against Prevotella P disiens by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL612235,Prevotella disiens,Prevotella disiens,28130.0,,MIC90,ug ml-1,UO_0000274,64.0
85446,,5221035,CHEMBL1680252,Antibacterial activity against Prevotella P intermedia by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC90,ug ml-1,UO_0000274,64.0
85447,,5221041,CHEMBL1680253,Antibacterial activity against Prevotella intermedia by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC90,ug ml-1,UO_0000274,64.0
85448,,5221047,CHEMBL1680254,Antibacterial activity against Prevotella nigrescens by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL615063,Prevotella nigrescens,Prevotella nigrescens,28133.0,,MIC90,ug ml-1,UO_0000274,64.0
85449,,5221053,CHEMBL1680255,Antibacterial activity against Prevotella loescheii by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL614607,Hoylesella loescheii,Hoylesella loescheii,840.0,,MIC90,ug ml-1,UO_0000274,64.0
85450,,5221059,CHEMBL1680256,Antibacterial activity against Prevotella melaninogenica by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,MIC90,ug ml-1,UO_0000274,64.0
85451,,5221065,CHEMBL1680257,Antibacterial activity against Prevotella oralis by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL612687,Hoylesella oralis,Hoylesella oralis,28134.0,,MIC90,ug ml-1,UO_0000274,64.0
85452,,5221071,CHEMBL1680258,Antibacterial activity against Prevotella oris by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,64.0
85453,,5221077,CHEMBL1680259,Antibacterial activity against Sutterella wadsworthensis by CLSI M11-A6 agar dilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,64.0
85454,,5221102,CHEMBL1680240,Antibacterial activity against Bacteroides ovatus by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,MIC,ug ml-1,UO_0000274,64.0
85455,,5221108,CHEMBL1680241,Antibacterial activity against Bacteroides thetaiotaomicron by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC,ug ml-1,UO_0000274,64.0
85456,,5221114,CHEMBL1680242,Antibacterial activity against Bacteroides vulgatus by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,MIC,ug ml-1,UO_0000274,64.0
85457,,5221120,CHEMBL1680243,Antibacterial activity against Bacteroides splanchnicus by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,64.0
85458,,5221126,CHEMBL1680244,Antibacterial activity against Bilophila wadsworthia by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,64.0
85459,,5221132,CHEMBL1680245,Antibacterial activity against Fusobacterium mortiferum by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,MIC,ug ml-1,UO_0000274,32.0
85460,,5221138,CHEMBL1680246,Antibacterial activity against Fusobacterium varium by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,MIC,ug ml-1,UO_0000274,32.0
85461,,5221144,CHEMBL1680247,Antibacterial activity against Prevotella bivia by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,MIC,ug ml-1,UO_0000274,0.12
85462,,5221150,CHEMBL1680248,Antibacterial activity against Prevotella buccae by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,MIC,ug ml-1,UO_0000274,0.12
85463,,5221156,CHEMBL1680249,Antibacterial activity against Prevotella corporis by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL615061,Prevotella corporis,Prevotella corporis,28128.0,,MIC,ug ml-1,UO_0000274,0.12
85464,,5221162,CHEMBL1680250,Antibacterial activity against Prevotella P denticola by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL615062,Prevotella denticola,Prevotella denticola,28129.0,,MIC,ug ml-1,UO_0000274,0.12
85465,,5221168,CHEMBL1680251,Antibacterial activity against Prevotella P disiens by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612235,Prevotella disiens,Prevotella disiens,28130.0,,MIC,ug ml-1,UO_0000274,0.12
85466,,5221174,CHEMBL1680252,Antibacterial activity against Prevotella P intermedia by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC,ug ml-1,UO_0000274,0.12
85467,,5221180,CHEMBL1680253,Antibacterial activity against Prevotella intermedia by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC,ug ml-1,UO_0000274,0.12
85468,,5221186,CHEMBL1680254,Antibacterial activity against Prevotella nigrescens by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL615063,Prevotella nigrescens,Prevotella nigrescens,28133.0,,MIC,ug ml-1,UO_0000274,0.12
85469,,5221192,CHEMBL1680255,Antibacterial activity against Prevotella loescheii by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614607,Hoylesella loescheii,Hoylesella loescheii,840.0,,MIC,ug ml-1,UO_0000274,0.12
85470,,5221198,CHEMBL1680256,Antibacterial activity against Prevotella melaninogenica by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,MIC,ug ml-1,UO_0000274,0.12
85471,,5221204,CHEMBL1680257,Antibacterial activity against Prevotella oralis by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612687,Hoylesella oralis,Hoylesella oralis,28134.0,,MIC,ug ml-1,UO_0000274,0.12
85472,,5221210,CHEMBL1680258,Antibacterial activity against Prevotella oris by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
85473,,5221216,CHEMBL1680259,Antibacterial activity against Sutterella wadsworthensis by CLSI M11-A6 agar dilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,64.0
85474,Not Active,5300813,CHEMBL1696232,"Antibacterial activity against vancomycin-susceptible Enterococcus faecalis JH2-2 assessed as dismorphic bacterial chains at 1 times MIC after 1 hr using 3,3'-dihexyloxacarbocyanine iodide dye by confocal microscopy",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338454,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85475,,5300823,CHEMBL1696223,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis JH2-2 using BHI broth by macrodilution method,F,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338454,=,1,0,=,Activity,ug ml-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,ug ml-1,UO_0000274,1.0
85476,,5300824,CHEMBL1696224,Antibacterial activity against vancomycin-susceptible VanA-type Enterococcus faecalis BM4316 using BHI broth by macrodilution method,F,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338454,=,1,0,=,Activity,ug ml-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,ug ml-1,UO_0000274,4.0
85477,,5300825,CHEMBL1696225,Antibacterial activity against vancomycin-susceptible VanB-type Enterococcus faecalis BM4275 using BHI broth by macrodilution method,F,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338454,=,1,0,=,Activity,ug ml-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,ug ml-1,UO_0000274,1.0
85478,Active,5300836,CHEMBL1696226,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis JH2-2 assessed as increase in cell size at 0.25 times MIC after 30 to 90 mins by flow cytometric analysis relative to control,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338454,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85479,Active,5300837,CHEMBL1696227,Antibacterial activity against vancomycin-susceptible VanA-type Enterococcus faecalis BM4316 assessed as increase in cell size at 0.25 times MIC after 30 to 90 mins by flow cytometric analysis relative to control,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338454,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85480,Active,5300838,CHEMBL1696228,Antibacterial activity against vancomycin-susceptible VanB-type Enterococcus faecalis BM4275 assessed as increase in cell size at 0.25 times MIC after 30 to 90 mins by flow cytometric analysis relative to control,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338454,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85481,Not Active,5300842,CHEMBL1696233,"Antibacterial activity against vancomycin-susceptible VanA-type Enterococcus faecalis BM4316 assessed as dismorphic bacterial chains at 1 times MIC after 1 hr using 3,3'-dihexyloxacarbocyanine iodide dye by confocal microscopy",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338454,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85482,Not Active,5300846,CHEMBL1696234,"Antibacterial activity against vancomycin-susceptible VanB-type Enterococcus faecalis BM4275 assessed as dismorphic bacterial chains at 1 times MIC after 1 hr using 3,3'-dihexyloxacarbocyanine iodide dye by confocal microscopy",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338454,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85483,Not Active,5300853,CHEMBL1696238,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis JH2-2 assessed as membrane potential/size ratio at 0.25 to 1 times MIC after 1 hr by confocal microscopy,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338454,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85484,Not Active,5300857,CHEMBL1696239,Antibacterial activity against vancomycin-susceptible VanA-type Enterococcus faecalis BM4316 assessed as membrane potential/size ratio at 0.25 to 1 times MIC after 1 hr by confocal microscopy,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338454,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85485,Not Active,5300861,CHEMBL1696240,Antibacterial activity against vancomycin-susceptible VanB-type Enterococcus faecalis BM4275 assessed as membrane potential/size ratio at 0.25 to 1 times MIC after 1 hr by confocal microscopy,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338454,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85486,Active,5300865,CHEMBL1696245,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis JH2-2 assessed as decrease in bacterial count at 4 times MIC after 180 mins using BHI broth,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338454,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85487,Active,5300869,CHEMBL1696246,Antibacterial activity against vancomycin-susceptible VanA-type Enterococcus faecalis BM4316 assessed as decrease in bacterial count at 4 times MIC after 180 mins using BHI broth,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338454,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85488,Active,5300873,CHEMBL1696247,Antibacterial activity against vancomycin-susceptible VanB-type Enterococcus faecalis BM4275 assessed as decrease in bacterial count at 4 times MIC after 180 mins using BHI broth,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338454,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
85489,Active,5300884,CHEMBL1696242,Drug uptake in vancomycin-susceptible Enterococcus faecalis JH2-2 assessed as red-fluorescent bacteria at 1 times MIC after 1 hr by flow cytometry,A,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338454,,1,0,,Drug uptake,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Drug uptake,,,
85490,Active,5300885,CHEMBL1696243,Drug uptake in vancomycin-susceptible VanA-type Enterococcus faecalis BM4316 assessed as red-fluorescent bacteria at 1 times MIC after 1 hr by flow cytometry,A,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338454,,1,0,,Drug uptake,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Drug uptake,,,
85491,Active,5300886,CHEMBL1696244,Drug uptake in vancomycin-susceptible VanB-type Enterococcus faecalis BM4275 assessed as red-fluorescent bacteria at 1 times MIC after 1 hr by flow cytometry,A,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687826,Antimicrob Agents Chemother,2011.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338454,,1,0,,Drug uptake,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Drug uptake,,,
85492,,5305435,CHEMBL1696168,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient at pH 7.4 after 48 hrs by broth microdilution method in absence of thymidine,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337314,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
85493,,5305447,CHEMBL1696169,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient at pH 7.4 after 48 hrs by broth microdilution method in presence of thymidine,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337314,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
85494,,5306487,CHEMBL1696170,Antibacterial activity against revertant Staphylococcus aureus at pH 7.4 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337314,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
85495,,5306499,CHEMBL1696171,Antibacterial activity against normal phenotype Staphylococcus aureus at pH 7.4 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337314,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
85496,,5306537,CHEMBL1696166,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth assessed as log reduction of extracellular CFU after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1337314,=,1,0,=,log10cfu,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,3.0
85497,Active,5306553,CHEMBL1696181,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU level after 24 hrs in presence of thymidine,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1337314,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85498,,5306571,CHEMBL1696177,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU level per mg of protein at up to 10'5 times MIC after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1337314,=,1,0,=,log10cfu,,-0.35,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,-0.35
85499,,5306583,CHEMBL1696178,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU level per mg of protein after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1337314,=,1,0,=,log10cfu,,0.52,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,0.52
85500,,5306595,CHEMBL1696179,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth assessed as log reduction of extracellular CFU level at up to 10'5 times MIC after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1337314,<,1,0,<,log10CFU/ml,,-4.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,-4.5
85501,,5306607,CHEMBL1696180,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth assessed as log reduction of extracellular CFU level after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1337314,=,1,0,=,log10CFU/ml,,0.88,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,0.88
85502,,5306619,CHEMBL1696305,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth at pH 5.5 after 48 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337314,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
85503,,5306631,CHEMBL1696306,Antibacterial activity against normal phenotype Staphylococcus aureus in cation-adjusted MH 2 broth at pH 5.5 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337314,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
85504,,5315448,CHEMBL1690240,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 56 (494) by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338168,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85505,,5315449,CHEMBL1690239,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 152 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338168,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
85506,,5315450,CHEMBL1690241,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus isolate 156 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338168,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85507,,5315451,CHEMBL1690242,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus isolate 145 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338168,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85508,,5315452,CHEMBL1690243,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 336 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338168,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85509,,5315453,CHEMBL1690244,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 360 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338168,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85510,,5315454,CHEMBL1690245,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 412 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338168,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85511,,5315455,CHEMBL1690246,Antibacterial activity against vancomycin-heteroresistant Staphylococcus aureus isolate 38 (Mu3) by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338168,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85512,,5315456,CHEMBL1690247,Antibacterial activity against vancomycin-heteroresistant Staphylococcus aureus isolate 443 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338168,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85513,,5315457,CHEMBL1690248,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 435 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338168,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
85514,,5315458,CHEMBL1690249,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 440 (A6298) by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338168,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
85515,,5315459,CHEMBL1690250,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 453 (NRS23) by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338168,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
85516,,5315460,CHEMBL1690251,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 454 (NRS404) by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338168,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
85517,Active,5315461,CHEMBL1690383,"Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 56 (494) infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 24 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85518,Active,5315462,CHEMBL1690384,"Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 152 infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 24 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85519,Active,5315463,CHEMBL1690385,"Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus isolate 156 infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 24 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85520,Active,5315464,CHEMBL1690386,"Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus isolate 145 infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 24 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85521,Active,5315465,CHEMBL1690387,"Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 336 infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 24 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85522,Active,5315466,CHEMBL1690388,"Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 360 infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 24 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85523,Active,5315467,CHEMBL1690389,"Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 412 infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 24 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85524,Active,5315468,CHEMBL1690390,"Antibacterial activity against vancomycin-heteroresistant Staphylococcus aureus isolate 38 (Mu3) infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 24 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85525,Active,5315469,CHEMBL1690391,"Antibacterial activity against vancomycin-heteroresistant Staphylococcus aureus isolate 443 infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 24 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85526,Active,5315470,CHEMBL1691119,"Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 435 infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 24 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85527,Active,5315471,CHEMBL1691120,"Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 440 (A6298) infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 24 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85528,Active,5315472,CHEMBL1691121,"Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 453 (NRS23) infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 24 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85529,Active,5315473,CHEMBL1691122,"Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 454 (NRS404) infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 24 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85530,Not Active,5315474,CHEMBL1691123,"Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus isolate 145 infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 48 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85531,Not Active,5315475,CHEMBL1691124,"Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus isolate 336 infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 48 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85532,Not Active,5315476,CHEMBL1691125,"Antibacterial activity against vancomycin-heteroresistant Staphylococcus aureus isolate 443 infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 48 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85533,Not Active,5315477,CHEMBL1691126,"Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 435 infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 48 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85534,Active,5315478,CHEMBL1691127,"Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 440 (A6298) infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 48 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85535,Active,5315479,CHEMBL1691128,"Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 453 (NRS23) infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 48 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85536,Active,5315480,CHEMBL1691129,"Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 454 (NRS404) infected in neutropenic BALB/c mouse lung infection model assessed as reduction of CFU at 40 mg/kg, ip administered every 12 hrs measured after 48 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL1687804,Antimicrob Agents Chemother,2010.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,1338168,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85537,,14661695,CHEMBL3270261,Antibacterial activity against methicillin-sensitive Staphylococcus aureus MTCC 737 assessed as growth inhibition by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL3259723,J Med Chem,2014.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/Nanomolar,2104390,=,1,1,=,MIC90,nM,300.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,uM,UO_0000065,0.3
85538,,14661706,CHEMBL3270262,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as growth inhibition by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL3259723,J Med Chem,2014.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/Nanomolar,2104390,=,1,1,=,MIC90,nM,300.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,uM,UO_0000065,0.3
85539,,14661726,CHEMBL3270264,Antibacterial activity against vancomycin-sensitive Enterococcus faecium ATCC 19634 assessed as growth inhibition by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL3259723,J Med Chem,2014.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/Nanomolar,2104390,=,1,1,=,MIC90,nM,150.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,uM,UO_0000065,0.15
85540,,14661737,CHEMBL3270265,Antibacterial activity against vancomycin-resistant VanA phenotype of Enterococcus faecium ATCC 51559 assessed as growth inhibition by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL3259723,J Med Chem,2014.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/Nanomolar,2104390,=,1,1,=,MIC90,nM,4000.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,uM,UO_0000065,4.0
85541,,18272518,CHEMBL4059020,Antibacterial activity against vancomycin/methicillin-susceptible Staphylococcus aureus Newman ATCC 5904 after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4052823,J Med Chem,2018.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3032867,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.25
85542,,18272567,CHEMBL4059021,Antibacterial activity against healthcare-associated methicillin-resistant/vancomycin-intermediate Staphylococcus aureus Mu50 after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4052823,J Med Chem,2018.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3032867,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,1.0
85543,,18272601,CHEMBL4059024,Antibacterial activity against glycopeptide-resistant Enterococcus faecium Efm-HS-0649 vanA after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4052823,J Med Chem,2018.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3032867,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,4.0
85544,,18272625,CHEMBL4059025,Antibacterial activity against glycopeptide-resistant Enterococcus faecium Efm-HS-06188 vanA after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4052823,J Med Chem,2018.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3032867,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8.0
85545,,18272649,CHEMBL4059026,Antibacterial activity against glycopeptide-resistant Enterococcus faecium Efm-HS-0847 vanM after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4052823,J Med Chem,2018.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3032867,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,4.0
85546,,18272673,CHEMBL4059027,Antibacterial activity against glycopeptide-resistant Enterococcus faecium Efm-HS-08257 vanM after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4052823,J Med Chem,2018.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3032867,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.12
85547,,18272697,CHEMBL4059028,Antibacterial activity against glycopeptide-resistant Enterococcus faecium Efm-HS-vb01 vanB after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4052823,J Med Chem,2018.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3032867,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,1.0
85548,Active,18272706,CHEMBL4059031,"Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 LAC infected in BALB/c mouse assessed as mouse survival rate at 7 mg/kg, ip administered as single dose measured after 10 days relative to control",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4052823,J Med Chem,2018.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,3032867,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85549,Active,18272710,CHEMBL4059032,"Antibacterial activity against healthcare-associated methicillin-resistant/vancomycin-intermediate Staphylococcus aureus Mu50 infected in BALB/c mouse assessed as decrease in liver CFU levels at 7 mg/kg, ip administered twice in 24 hrs interval measured after 5 days",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4052823,J Med Chem,2018.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,3032867,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85550,,20610364,CHEMBL4606129,Antibacterial activity against Staphylococcus aureus SMITH assessed as inhibition of bacterial growth incubated for 20 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4602723,J Med Chem,2020.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3467270,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85551,,20610369,CHEMBL4606130,Antibacterial activity against Staphylococcus aureus RN4220 assessed as inhibition of bacterial growth incubated for 20 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4602723,J Med Chem,2020.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3467270,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85552,,20610374,CHEMBL4606131,Antibacterial activity against methicillin-resistant Staphylococcus aureus SR3637 assessed as inhibition of bacterial growth incubated for 20 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4602723,J Med Chem,2020.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3467270,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
85553,,20610379,CHEMBL4606132,Antibacterial activity against Vancomycin-resistant Staphylococcus aureus HIP11714 assessed as inhibition of bacterial growth incubated for 20 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4602723,J Med Chem,2020.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3467270,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
85554,,20610384,CHEMBL4606133,Antibacterial activity against Vancomycin-resistant Staphylococcus aureus HIP11983 assessed as inhibition of bacterial growth incubated for 20 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4602723,J Med Chem,2020.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3467270,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
85555,,20610389,CHEMBL4606134,Antibacterial activity against Enterococcus faecalis SR1004 assessed as inhibition of bacterial growth incubated for 20 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4602723,J Med Chem,2020.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3467270,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
85556,,20610394,CHEMBL4606135,Antibacterial activity against Vancomycin-resistant Enterococcus faecalis SR7914 (VanA) assessed as inhibition of bacterial growth incubated for 20 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4602723,J Med Chem,2020.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3467270,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
85557,,20610399,CHEMBL4606136,Antibacterial activity against Vancomycin-resistant Enterococcus faecalis SR23630 (VanB) assessed as inhibition of bacterial growth incubated for 20 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4602723,J Med Chem,2020.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3467270,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
85558,,20610404,CHEMBL4606137,Antibacterial activity against Enterococcus faecium SR16972 assessed as inhibition of bacterial growth incubated for 20 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4602723,J Med Chem,2020.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3467270,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.5
85559,,20610409,CHEMBL4606138,Antibacterial activity against Vancomycin-resistant Enterococcus faecium SR7940 (VanA) assessed as inhibition of bacterial growth incubated for 20 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4602723,J Med Chem,2020.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3467270,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8.0
85560,,20610414,CHEMBL4606139,Antibacterial activity against Vancomycin-resistant Enterococcus faecium SR23598 (VanB) assessed as inhibition of bacterial growth incubated for 20 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4602723,J Med Chem,2020.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3467270,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.5
85561,,20610419,CHEMBL4606140,Antibacterial activity against Vancomycin-resistant Enterococcus faecium SRM1101 (c_VanB) assessed as inhibition of bacterial growth incubated for 20 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4602723,J Med Chem,2020.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3467270,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8.0
85562,,20610424,CHEMBL4606141,Antibacterial activity against Streptococcus pneumoniae type 1 assessed as inhibition of bacterial growth incubated for 20 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4602723,J Med Chem,2020.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3467270,<=,1,1,<=,MIC,ug.mL-1,0.063,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.063
85563,,20610429,CHEMBL4606142,Antibacterial activity against Streptococcus pneumoniae SR11031 (PRSP) assessed as inhibition of bacterial growth incubated for 20 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4602723,J Med Chem,2020.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3467270,<=,1,1,<=,MIC,ug.mL-1,0.063,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.063
85564,,20610434,CHEMBL4606143,Antibacterial activity against Streptococcus pneumoniae tupelo (VTSP) assessed as inhibition of bacterial growth incubated for 20 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4602723,J Med Chem,2020.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3467270,<=,1,1,<=,MIC,ug.mL-1,0.063,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.063
85565,Not Determined,20610439,CHEMBL4606144,Antibacterial activity against Escherichia coli JC2 assessed as inhibition of bacterial growth incubated for 20 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4602723,J Med Chem,2020.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,3467270,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
85566,Not Determined,20610444,CHEMBL4606145,Antibacterial activity against Klebsiella pneumoniae SR1 assessed as inhibition of bacterial growth incubated for 20 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4602723,J Med Chem,2020.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,,3467270,,1,0,,MIC,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,,,
85567,,22909372,CHEMBL4733944,"Terminal half life in human at 10 mg/kg, administered as single dose measured over 2 hrs",A,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,CHEMBL4732080,Eur J Med Chem,2021.0,CHEMBL507870,TELAVANCIN,CHEMBL507870,0,http://qudt.org/vocab/unit#Hour,3556842,=,1,1,=,T1/2,hr,7.5,CHEMBL612558,,ADMET,,,beta t1/2,hr,UO_0000032,7.5
85568,,2323255,CHEMBL1006879,Antifungal activity against Candida albicans at 200 ug/disk after 24 hrs by disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CO[C@@H]1O[C@@H](OC)c2c1ccc([C@@]1(C)CCCC(C)(C)C1)c2[C@@H](C)C(=O)O,CHEMBL1151253,J Nat Prod,2004.0,CHEMBL466575,MEMBRANOLIDE C,CHEMBL466575,0,http://qudt.org/vocab/unit#Millimeter,738636,=,1,1,=,IZ,mm,4.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,IZ,mm,UO_0000016,4.0
85569,,2323256,CHEMBL1006880,Antibiotic activity against Escherichia coli at 200 ug/disk after 24 hrs by disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CO[C@@H]1O[C@@H](OC)c2c1ccc([C@@]1(C)CCCC(C)(C)C1)c2[C@@H](C)C(=O)O,CHEMBL1151253,J Nat Prod,2004.0,CHEMBL466575,MEMBRANOLIDE C,CHEMBL466575,0,http://qudt.org/vocab/unit#Millimeter,738636,=,1,1,=,IZ,mm,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,8.0
85570,,2323257,CHEMBL1006881,Antibiotic activity against Staphylococcus aureus at 200 ug/disk after 24 hrs by disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CO[C@@H]1O[C@@H](OC)c2c1ccc([C@@]1(C)CCCC(C)(C)C1)c2[C@@H](C)C(=O)O,CHEMBL1151253,J Nat Prod,2004.0,CHEMBL466575,MEMBRANOLIDE C,CHEMBL466575,0,http://qudt.org/vocab/unit#Millimeter,738636,=,1,1,=,IZ,mm,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,0.0
85571,,20659941,CHEMBL4618070,"Selectivity index, ratio of cytotoxicity against mouse J774A.1 cells to antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 amastigotes infected in mouse J774A.1 cells",T,BAO_0000179,BAO_0000219,cell-based format,CO[C@@H]1O[C@@H](OC)c2c1ccc([C@@]1(C)CCCC(C)(C)C1)c2[C@@H](C)C(=O)O,CHEMBL4616650,J Nat Prod,2020.0,CHEMBL466575,MEMBRANOLIDE C,CHEMBL466575,0,,3478488,>,1,0,>,Ratio IC50,,166.0,CHEMBL612545,,Unchecked,,,Ratio IC50,,,166.0
85572,,20659962,CHEMBL4618068,Antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by DRAQ5 fluorescent probe based assay,F,BAO_0000190,BAO_0000218,organism-based format,CO[C@@H]1O[C@@H](OC)c2c1ccc([C@@]1(C)CCCC(C)(C)C1)c2[C@@H](C)C(=O)O,CHEMBL4616650,J Nat Prod,2020.0,CHEMBL466575,MEMBRANOLIDE C,CHEMBL466575,0,http://www.openphacts.org/units/Nanomolar,3478488,=,1,1,=,IC50,nM,800.0,CHEMBL367,Leishmania donovani,Leishmania donovani,5661.0,,IC50,uM,UO_0000065,0.8
85573,,1798137,CHEMBL856015,Antimicrobial activity against Staphylococcus aureus 209P by liquid broth method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1138223,J Med Chem,2006.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,620366,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
85574,,1798138,CHEMBL856016,Antimicrobial activity against Escherichia coli K12 W3110 by liquid broth method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1138223,J Med Chem,2006.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,620366,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
85575,,1833373,CHEMBL911559,Antibacterial activity against 10^6 CFU/ml Mycoplasma pulmonis MpUR1.1 after 48 hrs,F,BAO_0002146,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1142175,Antimicrob Agents Chemother,2007.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625827,=,1,1,=,MIC,ug.mL-1,3.6,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,3.6
85576,,1833376,CHEMBL911560,Antibacterial activity against 10^6 CFU/ml Mycoplasma pulmonis MpUR1.1 assessed as viable cell count after 2 hrs,F,BAO_0000179,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1142175,Antimicrob Agents Chemother,2007.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625827,=,1,0,=,MBC,ug ml-1,7.1,CHEMBL3879801,,NON-PROTEIN TARGET,,,MBC,ug ml-1,UO_0000274,7.1
85577,,1833381,CHEMBL911561,Ratio of MBC to MIC for Mycoplasma pulmonis MpUR1.1,F,BAO_0000193,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1142175,Antimicrob Agents Chemother,2007.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,625827,=,1,0,=,Ratio,,2.0,CHEMBL612545,,Unchecked,,,Ratio,,,2.0
85578,,1833384,CHEMBL911562,Antibacterial activity against 10^6 CFU/ml log-phase Mycoplasma pulmonis MpUR1.1 assessed as viable cell count at 3.12 uM after 1 hr relative to control,F,BAO_0001103,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1142175,Antimicrob Agents Chemother,2007.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://qudt.org/vocab/unit#Percent,625827,=,1,0,=,Activity,%,98.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,98.0
85579,,1833390,CHEMBL911568,Antibacterial activity against 10^6 CFU/ml log-phase Mycoplasma pulmonis MpUR1.1 assessed as viable cell count at 3.12 uM after 24 hrs relative to control,F,BAO_0001103,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1142175,Antimicrob Agents Chemother,2007.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://qudt.org/vocab/unit#Percent,625827,=,1,0,=,Activity,%,0.16,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,0.16
85580,Active,1834466,CHEMBL911566,Antibacterial activity against 10^6 CFU/ml growth-phase Mycoplasma pulmonis MpUR1.1 assessed as viable cell count after 2 hrs relative to control,F,BAO_0000375,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1142175,Antimicrob Agents Chemother,2007.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,625827,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
85581,,2279150,CHEMBL958343,Toxicity in human RBC assessed as hemolytic activity at 100 ug/ml after 24 hrs relative to control,T,BAO_0001103,BAO_0000219,cell-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://qudt.org/vocab/unit#Percent,754657,=,1,0,=,Activity,%,100.0,CHEMBL612558,,ADMET,,,Activity,%,UO_0000187,100.0
85582,,2279164,CHEMBL958344,Toxicity in human RBC assessed as fold reduction in hemolytic activity at 100 ug/ml after 24 hrs relative to control,T,BAO_0001103,BAO_0000219,cell-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://qudt.org/vocab/unit#Percent,754657,=,1,0,=,Activity,%,1.0,CHEMBL612558,,ADMET,,,Activity,%,UO_0000187,1.0
85583,,2279178,CHEMBL958345,Antimicrobial activity against Enterococcus faecalis after 24 hrs by standard microtiter dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754657,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
85584,,2279192,CHEMBL958346,Antimicrobial activity against Staphylococcus aureus after 24 hrs by standard microtiter dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754657,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
85585,,2279206,CHEMBL958347,Antimicrobial activity against Staphylococcus epidermidis after 24 hrs by standard microtiter dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754657,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
85586,,2279220,CHEMBL958348,Antimicrobial activity against Streptococcus mitis after 24 hrs by standard microtiter dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754657,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,0.5
85587,,2279234,CHEMBL958349,Antimicrobial activity against Streptococcus pneumoniae after 24 hrs by standard microtiter dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754657,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
85588,,2279248,CHEMBL958350,Antimicrobial activity against Streptococcus pyogenes after 24 hrs by standard microtiter dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754657,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.5
85589,,2279262,CHEMBL958351,Antimicrobial activity against Corynebacterium jeikeium after 24 hrs by standard microtiter dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754657,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL613351,Corynebacterium jeikeium,Corynebacterium jeikeium,38289.0,,MIC,ug ml-1,UO_0000274,4.0
85590,,2279276,CHEMBL958352,Antimicrobial activity against Acinetobacter calcoaceticus after 24 hrs by standard microtiter dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754657,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC,ug ml-1,UO_0000274,8.0
85591,,2279290,CHEMBL958353,Antimicrobial activity against Enterobacter cloacae after 24 hrs by standard microtiter dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754657,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,32.0
85592,,2279304,CHEMBL958354,Antimicrobial activity against Escherichia coli after 24 hrs by standard microtiter dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754657,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
85593,,2279318,CHEMBL958355,Antimicrobial activity against Klebsiella pneumoniae after 24 hrs by standard microtiter dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754657,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
85594,,2280000,CHEMBL958356,Antimicrobial activity against Pseudomonas aeruginosa after 24 hrs by standard microtiter dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754657,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
85595,,2280014,CHEMBL958357,Antimicrobial activity against Stenotrophomonas maltophilia after 24 hrs by standard microtiter dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754657,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,8.0
85596,,2280028,CHEMBL958358,Antimicrobial activity against Serratia marcescens after 24 hrs by standard microtiter dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754657,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,256.0
85597,,2280042,CHEMBL958359,Antimicrobial activity against Candida albicans after 24 hrs by standard microtiter dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754657,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,8.0
85598,,2280056,CHEMBL958360,Antimicrobial activity against Cryptococcus neoformans after 24 hrs by standard microtiter dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153373,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754657,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,MIC,ug ml-1,UO_0000274,1.0
85599,,2500471,CHEMBL984197,Antimicrobial activity against Staphylococcus aureus CECT 240 after 24 hrs,F,BAO_0003035,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1143367,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,750945,=,1,1,=,MIC50,nM,7900.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,uM,UO_0000065,7.9
85600,,2500481,CHEMBL984199,Antimicrobial activity against Listeria monocytogenes CECT 4032 after 24 hrs,F,BAO_0003035,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1143367,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,750945,=,1,1,=,MIC50,nM,6700.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC50,uM,UO_0000065,6.7
85601,,2500496,CHEMBL984201,Antimicrobial activity against Acinetobacter baumannii ATCC 19606 after 24 hrs,F,BAO_0003035,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1143367,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,750945,=,1,1,=,MIC50,nM,10100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,uM,UO_0000065,10.1
85602,,2500509,CHEMBL984203,Antimicrobial activity against colistin-resistant Acinetobacter baumannii 19606R after 24 hrs,F,BAO_0003035,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1143367,J Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,750945,=,1,1,=,MIC50,nM,13100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,uM,UO_0000065,13.1
85603,,2722412,CHEMBL1063603,Antibiotic activity against Bacillus subtilis NBRC 3513 by microplate dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153598,Bioorg Med Chem Lett,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829591,=,1,1,=,MIC,ug.mL-1,3.13,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,3.13
85604,,2722414,CHEMBL1063604,Antibiotic activity against Bacillus megaterium ATCC 19213 by microplate dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153598,Bioorg Med Chem Lett,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829591,=,1,1,=,MIC,ug.mL-1,3.13,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,MIC,ug ml-1,UO_0000274,3.13
85605,,2722416,CHEMBL1063605,Antibiotic activity against Staphylococcus epidermidis NBRC 12933 by microplate dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153598,Bioorg Med Chem Lett,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829591,=,1,1,=,MIC,ug.mL-1,3.13,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,3.13
85606,,2722418,CHEMBL1063606,Antibiotic activity against Staphylococcus aureus NBRC 12732 by microplate dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153598,Bioorg Med Chem Lett,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829591,=,1,1,=,MIC,ug.mL-1,3.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,3.13
85607,,2722420,CHEMBL1063607,Antibiotic activity against Pseudomonas aeruginosa NBRC 3080 by microplate dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153598,Bioorg Med Chem Lett,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829591,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,25.0
85608,,2722422,CHEMBL1063608,Antibiotic activity against Escherichia coli NBRC 12734 by microplate dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153598,Bioorg Med Chem Lett,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829591,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,25.0
85609,Dose-dependent effect,2722439,CHEMBL1063609,Cytotoxicity against human red blood cells assessed as hemolysis after 30 mins,A,BAO_0000375,BAO_0000219,cell-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1153598,Bioorg Med Chem Lett,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,829591,,1,0,,Activity,,,CHEMBL612558,,ADMET,,,Activity,,,
85610,,3000724,CHEMBL1045569,Antilysterial activity against leucocin A-sensitive Listeria monocytogenes B73 assessed as bacterial lysis per min at 10 uM by broth microdilution assay,F,BAO_0001103,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1155276,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://qudt.org/vocab/unit#Percent,856961,=,1,0,=,Activity,%,1.61,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,Activity,%,UO_0000187,1.61
85611,,3000731,CHEMBL1045570,Antilysterial activity against leucocin A-sensitive Listeria monocytogenes B73 assessed as bacterial lysis at 10 uM after 60 mins by broth microdilution assay,F,BAO_0001103,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1155276,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://qudt.org/vocab/unit#Percent,856961,=,1,0,=,Activity,%,70.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,Activity,%,UO_0000187,70.0
85612,,3000738,CHEMBL1045571,Antilysterial activity against leucocin A-sensitive Listeria monocytogenes B73 assessed as bacterial lysis half life at 10 uM by broth microdilution assay,F,BAO_0002115,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1155276,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://qudt.org/vocab/unit#Hour,856961,=,1,1,=,T1/2,hr,0.6417,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,t1/2,min,UO_0000032,38.5
85613,,3000745,CHEMBL1045572,Antibacterial activity against Micrococcus luteus NCTC 8340 after 16 hrs by broth microdilution assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1155276,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,856961,=,1,1,=,IC50,nM,6700.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,IC50,uM,UO_0000065,6.7
85614,,3000761,CHEMBL1043649,Antibacterial activity against leucocin A-sensitive Listeria monocytogenes B73 after 16 hrs by broth microdilution assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1155276,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,856961,=,1,1,=,IC50,nM,6600.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,IC50,uM,UO_0000065,6.6
85615,,3000777,CHEMBL1045433,Antibacterial activity against leucocin A-resistant Listeria monocytogenes B73-MR1 after 16 hrs by broth microdilution assay,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1155276,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,856961,=,1,1,=,IC50,nM,3900.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,IC50,uM,UO_0000065,3.9
85616,,3060826,CHEMBL1045074,Antibacterial activity against Streptococcus mitis ATCC 33399 after 24 to 96 hrs by well microplate assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1152538,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,876166,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,4.0
85617,,3060829,CHEMBL1044242,Antibacterial activity against Staphylococcus aureus 7323 after 24 to 96 hrs by well microplate assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1152538,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,876166,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
85618,,3060830,CHEMBL1044243,Antibacterial activity against Staphylococcus aureus 7388 after 24 to 96 hrs by well microplate assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1152538,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,876166,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
85619,,3060831,CHEMBL1044246,Antibacterial activity against Staphylococcus aureus CNS 7368 after 24 to 96 hrs by well microplate assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1152538,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,876166,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
85620,,3060832,CHEMBL1045072,Antibacterial activity against Pseudomonas aeruginosa ATCC 19582 after 24 to 96 hrs by well microplate assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1152538,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,876166,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
85621,,3060833,CHEMBL1045073,Antibacterial activity against Streptococcus mitis BMS after 24 to 96 hrs by well microplate assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1152538,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,876166,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,8.0
85622,,3060858,CHEMBL1044244,Antibacterial activity against Staphylococcus aureus CNS 5277 after 24 to 96 hrs by well microplate assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1152538,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,876166,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
85623,,3060859,CHEMBL1044245,Antibacterial activity against Staphylococcus aureus CNS 5115 after 24 to 96 hrs by well microplate assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1152538,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,876166,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
85624,,3060860,CHEMBL1044247,Antibacterial activity against Enterococcus faecalis 1131 after 24 to 96 hrs by well microplate assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1152538,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,876166,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,16.0
85625,,3060889,CHEMBL1044248,Antibacterial activity against Escherichia coli ATCC 25922 after 24 to 96 hrs by well microplate assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1152538,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,876166,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
85626,,3060909,CHEMBL1045071,Antibacterial activity against Pseudomonas aeruginosa AK1 after 24 to 96 hrs by well microplate assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1152538,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,876166,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
85627,,3060980,CHEMBL1045075,Cytotoxicity against human erythrocytes assessed as hemolysis after 4 hrs by twofold dilution assay,A,BAO_0000188,BAO_0000219,cell-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1152538,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,876166,=,1,1,=,EC50,nM,11700.0,CHEMBL612558,,ADMET,,,EC50,uM,UO_0000065,11.7
85628,,3060986,CHEMBL1045078,Cytotoxicity against human erythrocytes assessed as hemolysis at 12 uM after 4 hrs by twofold dilution assay,A,BAO_0001103,BAO_0000219,cell-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1152538,Bioorg Med Chem,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://qudt.org/vocab/unit#Percent,876166,=,1,0,=,Activity,%,50.0,CHEMBL612558,,ADMET,,,Activity,%,UO_0000187,50.0
85629,,3289425,CHEMBL1112992,Antibacterial activity against Staphylococcus aureus CECT 240 after 24 hrs by turbidimetry,F,BAO_0003035,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1157762,J Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,908776,=,1,1,=,MIC50,nM,7900.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,uM,UO_0000065,7.9
85630,,3289468,CHEMBL1112999,"Therapeutic index, ratio of HC50 for sheep erythrocytes to MIC50 for polymyxin E-resistant Acinetobacter baumannii ATCC 19606",A,BAO_0000193,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1157762,J Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,908776,=,1,0,=,Ratio,,1.6,CHEMBL612558,,ADMET,,,Ratio,,,1.6
85631,,3289470,CHEMBL1112997,"Therapeutic index, ratio of HC50 for sheep erythrocytes to MIC50 for polymyxin E-sensitive Acinetobacter baumannii ATCC 19606",A,BAO_0000193,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1157762,J Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,908776,=,1,0,=,Ratio,,1.9,CHEMBL612558,,ADMET,,,Ratio,,,1.9
85632,,3289474,CHEMBL1112995,"Therapeutic index, ratio of HC50 for sheep erythrocytes to MIC50 for Listeria monocytogenes CECT 4032",A,BAO_0000193,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1157762,J Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,908776,=,1,0,=,Ratio,,2.6,CHEMBL612558,,ADMET,,,Ratio,,,2.6
85633,,3289475,CHEMBL1112993,"Therapeutic index, ratio of HC50 for sheep erythrocytes to MIC50 for Staphylococcus aureus CECT 240",A,BAO_0000193,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1157762,J Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,908776,=,1,0,=,Ratio,,2.7,CHEMBL612558,,ADMET,,,Ratio,,,2.7
85634,,3289490,CHEMBL1112994,Antibacterial activity against Listeria monocytogenes CECT 4032 after 24 hrs by turbidimetry,F,BAO_0003035,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1157762,J Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,908776,=,1,1,=,MIC50,nM,8000.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC50,uM,UO_0000065,8.0
85635,,3289498,CHEMBL1112996,Antibacterial activity against polymyxin E-sensitive Acinetobacter baumannii ATCC 19606 after 24 hrs by turbidimetry,F,BAO_0003035,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1157762,J Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,908776,=,1,1,=,MIC50,nM,11000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,uM,UO_0000065,11.0
85636,,3289499,CHEMBL1112998,Antibacterial activity against polymyxin E-resistant Acinetobacter baumannii ATCC 19606 after 24 hrs by turbidimetry,F,BAO_0003035,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1157762,J Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,908776,=,1,1,=,MIC50,nM,13100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,uM,UO_0000065,13.1
85637,,3598552,CHEMBL1293173,"Therapeutic index, concentration required to achieve 100% hemolysis in erythrocyte to MIC for Escherichia coli ATCC 25922",A,BAO_0000193,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1287679,Bioorg Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,974048,=,1,0,=,Ratio,,2.0,CHEMBL612558,,ADMET,,,Ratio,,,2.0
85638,,3598580,CHEMBL1293171,Toxicity in Erythrocyte assessed as concentration required to achieve 100% hemolysis after 4 hrs,A,BAO_0000181,BAO_0000219,cell-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1287679,Bioorg Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Micromolar,974048,=,1,0,=,Activity,uM,62.5,CHEMBL612558,,ADMET,,,Activity,uM,UO_0000064,62.5
85639,,3598591,CHEMBL1293170,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1287679,Bioorg Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974048,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,8.0
85640,,3598602,CHEMBL1293169,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 49775 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1287679,Bioorg Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974048,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,8.0
85641,,3598614,CHEMBL1293168,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N133 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1287679,Bioorg Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974048,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,16.0
85642,,3598626,CHEMBL1293167,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N229 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1287679,Bioorg Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974048,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,8.0
85643,,3598638,CHEMBL1293166,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate 1110301981 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1287679,Bioorg Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974048,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,16.0
85644,,3598650,CHEMBL1293165,Antimicrobial activity against community acquired methicillin-resistant Staphylococcus aureus isolate 1110301146 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1287679,Bioorg Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974048,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,16.0
85645,,3598664,CHEMBL1293161,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1287679,Bioorg Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,32.0
85646,,3599029,CHEMBL1293162,Antimicrobial activity against Escherichia coli ATCC 25922 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1287679,Bioorg Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974048,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,64.0
85647,,3599043,CHEMBL1293163,Antimicrobial activity against Bacillus cereus ATCC 11778 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1287679,Bioorg Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974048,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,mg/L,UO_0000274,8.0
85648,,3599057,CHEMBL1293164,Antimicrobial activity against Enterococcus faecalis ATCC 29212 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1287679,Bioorg Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974048,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,mg/L,UO_0000274,8.0
85649,,3599071,CHEMBL1293159,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1287679,Bioorg Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974048,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,mg/L,UO_0000274,8.0
85650,,3599085,CHEMBL1293160,Antimicrobial activity against Staphylococcus aureus ATCC 29213 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1287679,Bioorg Med Chem,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974048,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,32.0
85651,,5174655,CHEMBL1665330,Antibacterial activity against Aeromonas bestiarum DSM 13956 in presence of silver nanoparticles,F,BAO_0000179,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,=,1,0,=,FICI,,0.63,CHEMBL3879801,,NON-PROTEIN TARGET,,,FICI,,,0.63
85652,,5174661,CHEMBL1665329,Antibacterial activity against Enterobacter helveticus DSM 18396 in presence of silver nanoparticles,F,BAO_0000179,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,=,1,0,=,FICI,,0.44,CHEMBL3879801,,NON-PROTEIN TARGET,,,FICI,,,0.44
85653,Not Determined,5174667,CHEMBL1665328,Antibacterial activity against Acinetobacter calcoaceticus DSM 586 in presence of silver nanoparticles,F,BAO_0000179,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,,1,0,,FICI,,,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,FICI,,,
85654,,5174673,CHEMBL1665327,Antibacterial activity against Escherichia coli DSM 498 in presence of silver nanoparticles,F,BAO_0000179,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,=,1,0,=,FICI,,0.56,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FICI,,,0.56
85655,,5174679,CHEMBL1665326,Antibacterial activity against Micrococcus luteus DSM 1790 in presence of silver nitrate,F,BAO_0000179,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,=,1,0,=,FICI,,0.92,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,FICI,,,0.92
85656,,5174685,CHEMBL1665325,Antibacterial activity against Kocuria rhizophila DSM 348 in presence of silver nitrate,F,BAO_0000179,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,=,1,0,=,FICI,,0.92,CHEMBL1075349,Kocuria rhizophila,Kocuria rhizophila,72000.0,,FICI,,,0.92
85657,,5174691,CHEMBL1665324,Antibacterial activity against Bacillus subtilis DSM 347 in presence of silver nitrate,F,BAO_0000179,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,=,1,0,=,FICI,,0.73,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,FICI,,,0.73
85658,,5174697,CHEMBL1665323,Antibacterial activity against Pseudomonas fluorescens DSM 50090 in presence of silver nitrate,F,BAO_0000179,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,=,1,0,=,FICI,,0.67,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,FICI,,,0.67
85659,,5174703,CHEMBL1665322,Antibacterial activity against Proteus myxofaciens DSM 4482 in presence of silver nitrate,F,BAO_0000179,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,=,1,0,=,FICI,,0.63,CHEMBL3879801,,NON-PROTEIN TARGET,,,FICI,,,0.63
85660,,5174709,CHEMBL1665321,Antibacterial activity against Aeromonas bestiarum DSM 13956 in presence of silver nitrate,F,BAO_0000179,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,=,1,0,=,FICI,,0.53,CHEMBL3879801,,NON-PROTEIN TARGET,,,FICI,,,0.53
85661,,5174715,CHEMBL1665320,Antibacterial activity against Enterobacter helveticus DSM 18396 in presence of silver nitrate,F,BAO_0000179,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,=,1,0,=,FICI,,0.32,CHEMBL3879801,,NON-PROTEIN TARGET,,,FICI,,,0.32
85662,,5174721,CHEMBL1665319,Antibacterial activity against Acinetobacter calcoaceticus DSM 586 in presence of silver nitrate,F,BAO_0000179,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,=,1,0,=,FICI,,0.77,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,FICI,,,0.77
85663,,5174727,CHEMBL1665318,Antibacterial activity against Escherichia coli DSM 498 in presence of silver nitrate,F,BAO_0000179,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,=,1,0,=,FICI,,0.83,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FICI,,,0.83
85664,,5174733,CHEMBL1665317,Antibacterial activity against Micrococcus luteus DSM 1790,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321853,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,2.0
85665,,5174741,CHEMBL1665316,Antibacterial activity against Kocuria rhizophila DSM 348,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321853,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL1075349,Kocuria rhizophila,Kocuria rhizophila,72000.0,,MIC,ug ml-1,UO_0000274,4.0
85666,,5174749,CHEMBL1665315,Antibacterial activity against Bacillus subtilis DSM 347,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321853,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,2.0
85667,,5174757,CHEMBL1665314,Antibacterial activity against Pseudomonas fluorescens DSM 50090,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321853,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,MIC,ug ml-1,UO_0000274,16.0
85668,,5174765,CHEMBL1665313,Antibacterial activity against Proteus myxofaciens DSM 4482,F,BAO_0002146,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321853,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,16.0
85669,,5174773,CHEMBL1665312,Antibacterial activity against Aeromonas bestiarum DSM 13956,F,BAO_0002146,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321853,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,32.0
85670,,5174781,CHEMBL1665311,Antibacterial activity against Enterobacter helveticus DSM 18396,F,BAO_0002146,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321853,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,4.0
85671,,5174789,CHEMBL1665310,Antibacterial activity against Acinetobacter calcoaceticus DSM 586,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321853,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC,ug ml-1,UO_0000274,16.0
85672,,5174796,CHEMBL1652852,Antibacterial activity against Escherichia coli DSM 498,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321853,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
85673,,5174805,CHEMBL1665331,Antibacterial activity against Proteus myxofaciens DSM 4482 in presence of silver nanoparticles,F,BAO_0000179,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,=,1,0,=,FICI,,0.38,CHEMBL3879801,,NON-PROTEIN TARGET,,,FICI,,,0.38
85674,,5174811,CHEMBL1665332,Antibacterial activity against Pseudomonas fluorescens DSM 50090 in presence of silver nanoparticles,F,BAO_0000179,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,=,1,0,=,FICI,,0.48,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,FICI,,,0.48
85675,,5174817,CHEMBL1665333,Antibacterial activity against Bacillus subtilis DSM 347 in presence of silver nanoparticles,F,BAO_0000179,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,=,1,0,=,FICI,,0.77,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,FICI,,,0.77
85676,,5174823,CHEMBL1665334,Antibacterial activity against Kocuria rhizophila DSM 348 in presence of silver nanoparticles,F,BAO_0000179,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,=,1,0,=,FICI,,0.83,CHEMBL1075349,Kocuria rhizophila,Kocuria rhizophila,72000.0,,FICI,,,0.83
85677,,5174829,CHEMBL1665335,Antibacterial activity against Micrococcus luteus DSM 1790 in presence of silver nanoparticles,F,BAO_0000179,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1649572,Antimicrob Agents Chemother,2009.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,1321853,=,1,0,=,FICI,,1.25,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,FICI,,,1.25
85678,,5229902,CHEMBL1677695,Antimicrobial activity against Pseudomonas aeruginosa PAO1 H103,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1671728,Antimicrob Agents Chemother,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332548,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.2
85679,Not Active,5229932,CHEMBL1677700,Inhibition of DNA polymerase assessed as reduction in PCR products at MIC for Pseudomonas aeruginosa PAO1 H103 by qPCR,B,BAO_0000201,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1671728,Antimicrob Agents Chemother,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://qudt.org/vocab/unit#Percent,1332548,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
85680,Not Determined,5229953,CHEMBL1677699,Inhibition of DnaK assessed as reduction in ATP turnover at MIC for Pseudomonas aeruginosa PAO1 H103 by ATPase assay,B,BAO_0000201,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1671728,Antimicrob Agents Chemother,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://qudt.org/vocab/unit#Percent,1332548,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
85681,Not Active,5229975,CHEMBL1677698,Inhibition of Photinus pyralis fire fly luciferase assessed as reduction in light production at 10 times MIC for Pseudomonas aeruginosa PAO1 H103 by ATP bioluminescence assay,B,BAO_0000201,BAO_0000357,single protein format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1671728,Antimicrob Agents Chemother,2010.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://qudt.org/vocab/unit#Percent,1332548,,1,0,,Inhibition,%,,CHEMBL5567,Photinus pyralis,Luciferin 4-monooxygenase,7054.0,,INH,,UO_0000187,
85682,,6308078,CHEMBL1816525,Antimicrobial activity against Enterobacter cloacae 1190900252 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1811906,Bioorg Med Chem,2011.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1449248,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,mg/L,UO_0000274,64.0
85683,,6308086,CHEMBL1815916,Antimicrobial activity against Klebsiella pneumoniae 1190901525 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1811906,Bioorg Med Chem,2011.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1449248,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,64.0
85684,,6308092,CHEMBL1815915,Antimicrobial activity against Escherichia coli ATCC 25922 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1811906,Bioorg Med Chem,2011.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1449248,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,32.0
85685,,6308105,CHEMBL1815914,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1811906,Bioorg Med Chem,2011.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1449248,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,64.0
85686,,6308113,CHEMBL1815913,Antimicrobial activity against Bacillus cereus ATCC 11778 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1811906,Bioorg Med Chem,2011.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1449248,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,mg/L,UO_0000274,4.0
85687,,6308125,CHEMBL1815912,Antimicrobial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1811906,Bioorg Med Chem,2011.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1449248,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,mg/L,UO_0000274,8.0
85688,,6308136,CHEMBL1815911,Antimicrobial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1811906,Bioorg Med Chem,2011.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1449248,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,4.0
85689,,6308146,CHEMBL1815909,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1811906,Bioorg Med Chem,2011.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1449248,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,mg/L,UO_0000274,4.0
85690,,6308171,CHEMBL1816526,Antimicrobial activity against Proteus mirabilis 1190901236 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1811906,Bioorg Med Chem,2011.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1449248,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,64.0
85691,,7992388,CHEMBL1936422,Antibacterial activity against Escherichia coli NBRC 12734 after overnight incubation by microplate dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1933037,Bioorg Med Chem Lett,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1568558,=,1,1,=,MIC,ug.mL-1,25000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/ml,UO_0000274,25.0
85692,,7992397,CHEMBL1936421,Antibacterial activity against Pseudomonas aeruginosa NBRC 3080 after overnight incubation by microplate dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1933037,Bioorg Med Chem Lett,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1568558,=,1,1,=,MIC,ug.mL-1,25000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/ml,UO_0000274,25.0
85693,,7992406,CHEMBL1936420,Antibacterial activity against Staphylococcus aureus NBRC 12732 after overnight incubation by microplate dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1933037,Bioorg Med Chem Lett,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1568558,=,1,1,=,MIC,ug.mL-1,3130.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/ml,UO_0000274,3.13
85694,,7992415,CHEMBL1936419,Antibacterial activity against Staphylococcus epidermidis NBRC 12933 after overnight incubation by microplate dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1933037,Bioorg Med Chem Lett,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1568558,=,1,1,=,MIC,ug.mL-1,3130.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,mg/ml,UO_0000274,3.13
85695,,7992424,CHEMBL1936418,Antibacterial activity against Bacillus megaterium ATCC 19213 after overnight incubation by microplate dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1933037,Bioorg Med Chem Lett,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1568558,=,1,1,=,MIC,ug.mL-1,3130.0,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,MIC,mg/ml,UO_0000274,3.13
85696,,7992433,CHEMBL1936417,Antibacterial activity against Bacillus subtilis NBRC 3513 after overnight incubation by microplate dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1933037,Bioorg Med Chem Lett,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1568558,=,1,1,=,MIC,ug.mL-1,3130.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,mg/ml,UO_0000274,3.13
85697,,12038386,CHEMBL2148514,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL2146376,Bioorg Med Chem,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1727761,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
85698,,12038401,CHEMBL2148515,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL2146376,Bioorg Med Chem,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1727761,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
85699,,12038416,CHEMBL2148516,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL2146376,Bioorg Med Chem,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1727761,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,16.0
85700,,12038431,CHEMBL2148517,Antibacterial activity against Bacillus cereus ATCC 11778 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL2146376,Bioorg Med Chem,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1727761,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,8.0
85701,,12038446,CHEMBL2148518,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL2146376,Bioorg Med Chem,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1727761,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
85702,,12039063,CHEMBL2148519,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL2146376,Bioorg Med Chem,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1727761,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
85703,,12039078,CHEMBL2148520,Antibacterial activity against PVL-positive and non-typable methicillin-resistant Staphylococcus aureus 1110301981H-T034 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL2146376,Bioorg Med Chem,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1727761,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
85704,,12039092,CHEMBL2148521,Antibacterial activity against PVL-deficient and non-typable methicillin-resistant Staphylococcus aureus N133-T034 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL2146376,Bioorg Med Chem,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1727761,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
85705,,12039106,CHEMBL2148522,Antibacterial activity against PVL-deficient and non-typable methicillin-resistant Staphylococcus aureus N229-T034 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL2146376,Bioorg Med Chem,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1727761,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
85706,,12039120,CHEMBL2148523,Antibacterial activity against PVL-positive and non-typable methicillin-resistant Staphylococcus aureus USA300-1110301146 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL2146376,Bioorg Med Chem,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1727761,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
85707,,12039134,CHEMBL2148524,Toxicity in human erythrocytes assessed as concentration required to achieve 100% hemolysis after 4 hrs,T,BAO_0000181,BAO_0000219,cell-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL2146376,Bioorg Med Chem,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Micromolar,1727761,=,1,0,=,Activity,uM,31.3,CHEMBL612558,,ADMET,,,Activity,uM,UO_0000064,31.3
85708,active,14033879,CHEMBL3215017,PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS.   (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1201862,,,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,1860283,,7,1,,Potency,nM,4466.8,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,4.4668
85709,active,14120154,CHEMBL3215099,PubChem BioAssay. qHTS profiling of Chloroquine Analogs as inhibitors of Plasmodium falciparum (DD2) proliferation.   (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1201862,,,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,2037066,,7,1,,Potency,nM,0.7,CHEMBL3879801,,NON-PROTEIN TARGET,,,Potency,uM,UO_0000065,0.0007
85710,active,14157676,CHEMBL3215169,PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ,B,BAO_0000186,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1201862,,,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,1860283,,7,1,,Potency,nM,31622.8,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,31.6228
85711,inconclusive,14290559,CHEMBL3215270,PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS.   (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1201862,,,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,1860283,,7,1,,Potency,nM,5011.9,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,5.0119
85712,inconclusive,14396353,CHEMBL3214913,PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ,B,BAO_0000186,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1201862,,,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,1860283,,7,1,,Potency,nM,6309.6,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,6.3096
85713,active,14455788,CHEMBL3214970,PubChem BioAssay. qHTS Assay for Identifying Gametocytocidal Compounds.   (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1201862,,,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,1860283,,7,1,,Potency,nM,2238.7,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,2.2387
85714,Not Active,14533758,CHEMBL3225450,Inhibition of AAC(6')-li (unknown origin),B,BAO_0000201,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL3217485,Medchemcomm,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://qudt.org/vocab/unit#Percent,2077109,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
85715,,14533771,CHEMBL3225451,Inhibition of AAC(6')-le (unknown origin),B,BAO_0000190,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL3217485,Medchemcomm,2012.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,2077109,=,1,1,=,IC50,nM,14000.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,14.0
85716,,14550289,CHEMBL3223895,Antimicrobial activity against Staphylococcus aureus FDA 209P after 20 hrs by liquid microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL3217536,Medchemcomm,2011.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,2077436,=,1,1,=,MIC,nM,3000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,3.0
85717,,14550293,CHEMBL3223902,Antimicrobial activity against Escherichia coli K-12 W3110 after 20 hrs by liquid microdilution method in presence of PMBN,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL3217536,Medchemcomm,2011.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2077436,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
85718,,14552439,CHEMBL3223896,Antimicrobial activity against Escherichia coli K-12 W3110 after 20 hrs by liquid microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL3217536,Medchemcomm,2011.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,2077436,=,1,1,=,MIC,nM,13000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,13.0
85719,Dose-dependent effect,14552452,CHEMBL3223898,Induction of cytoplasmic membrane disruption in Staphylococcus aureus FDA 209P assessed as change in potassium permeability after 30 mins,F,BAO_0000375,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL3217536,Medchemcomm,2011.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,2077436,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85720,,14552465,CHEMBL3223898,Induction of cytoplasmic membrane disruption in Staphylococcus aureus FDA 209P assessed as change in potassium permeability after 30 mins,F,BAO_0003036,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL3217536,Medchemcomm,2011.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Micromolar,2077436,=,1,0,=,ED50,uM,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,ED50,uM,UO_0000064,2.0
85721,,14552469,CHEMBL3223900,Induction of cytoplasmic membrane disruption in Escherichia coli K-12 W3110 assessed as change in potassium permeability after 30 mins,F,BAO_0003036,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL3217536,Medchemcomm,2011.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Micromolar,2077436,=,1,0,=,ED50,uM,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,ED50,uM,UO_0000064,20.0
85722,,14552473,CHEMBL3223897,Hemolytic activity against human erythrocytes,A,BAO_0003036,BAO_0000219,cell-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL3217536,Medchemcomm,2011.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Micromolar,2077436,=,1,0,=,ED50,uM,5.0,CHEMBL612558,,ADMET,,,ED50,uM,UO_0000064,5.0
85723,active,15528604,CHEMBL3562077,PubChem BioAssay. High Throughput Screening for Foot and Mouth Disease Virus Antivirals.   (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL1201862,,,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,1860283,,7,1,,Potency,nM,6309.6,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,6.3096
85724,No. Measurements = 1,22085490,CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL4651402,,2021.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,3493851,>,57,1,>,IC50,nM,20000.0,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,IC50,M,UO_0000065,2e-05
85725,No. Measurements = 1,22085491,CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000190,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL4651402,,2021.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,http://www.openphacts.org/units/Nanomolar,3493851,<,57,1,>,IC50,nM,19952.62,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,pIC50,,UO_0000065,4.7
85726,Active,24882265,CHEMBL5156262,Bacteriolytic activity against Escherichia coli LMG 8223 incubated for 2 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL5154669,J Med Chem,2022.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,3888715,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
85727,Active,24882270,CHEMBL5156263,Bacteriolytic activity against Bacillus cereus ATCC 10987 incubated for 2 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL5154669,J Med Chem,2022.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,3888715,,1,0,,Activity,,,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,Activity,,,
85728,Active,24882275,CHEMBL5156264,Bacteriolytic activity against Enterococcus faecium LMG 16003 incubated for 2 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL5154669,J Med Chem,2022.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,3888715,,1,0,,Activity,,,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,,,
85729,Active,24882280,CHEMBL5156265,Bacteriolytic activity against Staphylococcus aureus LMG 8224 incubated for 2 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL5154669,J Med Chem,2022.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,3888715,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85730,Active,25081880,CHEMBL5255973,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as cell wall loosening at 5 x MIC incubated for 2 hrs by transmission electron microscopy analysis,F,BAO_0000375,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL5252628,Bioorg Med Chem,2023.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,3931814,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85731,Active,25081883,CHEMBL5255974,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as blurred space in cytoplasm and cell wall at 5 x MIC incubated for 2 hrs by transmission electron microscopy analysis,F,BAO_0000375,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL5252628,Bioorg Med Chem,2023.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,3931814,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85732,Active,25081886,CHEMBL5255975,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as separation of plasma wall at 5 x MIC incubated for 2 hrs by transmission electron microscopy analysis,F,BAO_0000375,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL5252628,Bioorg Med Chem,2023.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,3931814,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85733,Active,25081889,CHEMBL5255977,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as appearance of cell round pellet at 5 x MIC incubated for 2 hrs by transmission electron microscopy analysis,F,BAO_0000375,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL5252628,Bioorg Med Chem,2023.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,3931814,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85734,Active,25081892,CHEMBL5255978,Antibacterial activity against methicillin-resistant Staphylococcus aureus 2 assessed as cell wall loosening at 5 x MIC incubated for 2 hrs by transmission electron microscopy analysis,F,BAO_0000375,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL5252628,Bioorg Med Chem,2023.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,3931814,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85735,Active,25081895,CHEMBL5255979,Antibacterial activity against methicillin-resistant Staphylococcus aureus 2 assessed as blurred space in cytoplasm and cell wall at 5 x MIC incubated for 2 hrs by transmission electron microscopy analysis,F,BAO_0000375,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL5252628,Bioorg Med Chem,2023.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,3931814,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85736,Active,25081898,CHEMBL5255980,Antibacterial activity against methicillin-resistant Staphylococcus aureus 2 assessed as separation of plasma wall at 5 x MIC incubated for 2 hrs by transmission electron microscopy analysis,F,BAO_0000375,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL5252628,Bioorg Med Chem,2023.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,3931814,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85737,Active,25081901,CHEMBL5255982,Antibacterial activity against methicillin-resistant Staphylococcus aureus 2 assessed as appearance of cell round pellet at 5 x MIC incubated for 2 hrs by transmission electron microscopy analysis,F,BAO_0000375,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL5252628,Bioorg Med Chem,2023.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,3931814,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
85738,Active,25081919,CHEMBL5255990,Induction of cell membrane disruption in Staphylococcus aureus ATCC 29213 assessed as increase in protein leakage at 5 x MIC incubated for 2 hrs by coomassie brilliant blue dye assay,B,BAO_0000375,BAO_0000220,subcellular format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL5252628,Bioorg Med Chem,2023.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,3931814,,1,0,,Activity,,,CHEMBL2364031,Bacteria,Cell membrane,2.0,,Activity,,,
85739,Active,25081921,CHEMBL5255991,Induction of cell membrane disruption in methicillin-resistant Staphylococcus aureus 2 assessed as increase in protein leakage at 5 x MIC incubated for 2 hrs by coomassie brilliant blue dye assay,B,BAO_0000375,BAO_0000220,subcellular format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,CHEMBL5252628,Bioorg Med Chem,2023.0,CHEMBL373496,GRAMICIDIN S,CHEMBL373496,0,,3931814,,1,0,,Activity,,,CHEMBL2364031,Bacteria,Cell membrane,2.0,,Activity,,,
85740,,223681,CHEMBL650360,Percent inhibition of [75Se]- selenomethionine incorporation in the protein synthesis assay in bone marrow cell lines at a concentration of 10 E-3,F,BAO_0000201,BAO_0000219,cell-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1122387,J Med Chem,1983.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://qudt.org/vocab/unit#Percent,63374,=,1,1,=,Inhibition,%,29.0,CHEMBL614359,,Osteoclast-like,,,Inhibition,%,UO_0000187,29.0
85741,,277950,CHEMBL673439,The compound was tested for inhibition of Puromycin reaction in Escherichia coli ribosome system at concentration of 1*10e-7 M,F,BAO_0000201,BAO_0000218,organism-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1126976,J Med Chem,1993.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://qudt.org/vocab/unit#Percent,28299,=,1,1,=,Inhibition,%,50.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Inhibition,%,UO_0000187,50.6
85742,,277951,CHEMBL873644,The compound was tested for inhibition of Puromycin reaction in Escherichia coli ribosome system at concentration of 1*10e-6 M,F,BAO_0000201,BAO_0000218,organism-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1126976,J Med Chem,1993.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://qudt.org/vocab/unit#Percent,28299,=,1,1,=,Inhibition,%,13.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Inhibition,%,UO_0000187,13.7
85743,,277952,CHEMBL673438,The compound was tested for inhibition of Puromycin reaction in Escherichia coli ribosome system at concentration of 1*10e-5 M,F,BAO_0000201,BAO_0000218,organism-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1126976,J Med Chem,1993.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://qudt.org/vocab/unit#Percent,28299,=,1,1,=,Inhibition,%,2.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Inhibition,%,UO_0000187,2.8
85744,,277953,CHEMBL673437,The compound was tested for inhibition of Puromycin reaction in Escherichia coli ribosome system at concentration of 1*10e-4 M,F,BAO_0000201,BAO_0000218,organism-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1126976,J Med Chem,1993.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://qudt.org/vocab/unit#Percent,28299,=,1,1,=,Inhibition,%,1.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Inhibition,%,UO_0000187,1.1
85745,,277954,CHEMBL673436,The compound was tested for inhibition of Puromycin reaction in Escherichia coli ribosome system at concentration of 1*10e-3 M,F,BAO_0000201,BAO_0000218,organism-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1126976,J Med Chem,1993.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://qudt.org/vocab/unit#Percent,28299,=,1,1,=,Inhibition,%,1.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Inhibition,%,UO_0000187,1.8
85746,,277955,CHEMBL673430,The compound was tested for inhibition of Polyphenylalanine synthesis with hybrid antibiotics in Escherichia coli ribosome system at concentration of 1*10e-6 M,F,BAO_0000201,BAO_0000218,organism-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1126976,J Med Chem,1993.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://qudt.org/vocab/unit#Percent,28299,=,1,1,=,Inhibition,%,77.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Inhibition,%,UO_0000187,77.3
85747,,277956,CHEMBL673431,The compound was tested for inhibition of Polyphenylalanine synthesis with hybrid antibiotics in Escherichia coli ribosome system at concentration of 5*10e-6 M,F,BAO_0000201,BAO_0000218,organism-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1126976,J Med Chem,1993.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://qudt.org/vocab/unit#Percent,28299,=,1,1,=,Inhibition,%,52.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Inhibition,%,UO_0000187,52.8
85748,,277957,CHEMBL673433,The compound was tested for inhibition of Polyphenylalanine synthesis with hybrid antibiotics in Escherichia coli ribosome system at concentration of at 1*10e-5 M,F,BAO_0000201,BAO_0000218,organism-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1126976,J Med Chem,1993.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://qudt.org/vocab/unit#Percent,28299,=,1,1,=,Inhibition,%,41.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Inhibition,%,UO_0000187,41.3
85749,,277958,CHEMBL673429,The compound was tested for inhibition of Polyphenylalanine synthesis with hybrid antibiotics in Escherichia coli ribosome system at concentration of 1*10e-4 M,F,BAO_0000201,BAO_0000218,organism-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1126976,J Med Chem,1993.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://qudt.org/vocab/unit#Percent,28299,=,1,1,=,Inhibition,%,39.4,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Inhibition,%,UO_0000187,39.4
85750,,277959,CHEMBL673432,The compound was tested for inhibition of Polyphenylalanine synthesis with hybrid antibiotics in Escherichia coli ribosome system at concentration of at 1*10e-3 M,F,BAO_0000201,BAO_0000218,organism-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1126976,J Med Chem,1993.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://qudt.org/vocab/unit#Percent,28299,=,1,1,=,Inhibition,%,20.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Inhibition,%,UO_0000187,20.2
85751,,277960,CHEMBL796789,The compound was tested for inhibition of Polyphenylalanine synthesis in Saccharomyces cerevisiae ribosome system at concentration of 1*10e-5 M,F,BAO_0000201,BAO_0000019,assay format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1126976,J Med Chem,1993.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://qudt.org/vocab/unit#Percent,28299,=,1,1,=,Inhibition,%,44.1,CHEMBL612558,,ADMET,,,Inhibition,%,UO_0000187,44.1
85752,,277961,CHEMBL796788,The compound was tested for inhibition of Polyphenylalanine synthesis in Saccharomyces cerevisiae ribosome system at concentration of 1*10e-4 M,F,BAO_0000201,BAO_0000019,assay format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1126976,J Med Chem,1993.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://qudt.org/vocab/unit#Percent,28299,=,1,1,=,Inhibition,%,30.3,CHEMBL612558,,ADMET,,,Inhibition,%,UO_0000187,30.3
85753,,277962,CHEMBL796787,The compound was tested for inhibition of Polyphenylalanine synthesis in Saccharomyces cerevisiae ribosome system at concentration of 1*10e-3 M,F,BAO_0000201,BAO_0000019,assay format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1126976,J Med Chem,1993.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://qudt.org/vocab/unit#Percent,28299,=,1,1,=,Inhibition,%,15.5,CHEMBL612558,,ADMET,,,Inhibition,%,UO_0000187,15.5
85754,,2380724,CHEMBL944335,Inhibition of protein synthesis in Escherichia coli S30 extract by translation assay,F,BAO_0000190,BAO_0000218,organism-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1152283,Bioorg Med Chem Lett,2008.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://www.openphacts.org/units/Nanomolar,804105,<=,1,1,<=,IC50,nM,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,uM,UO_0000065,0.02
85755,,2380730,CHEMBL944336,Antimicrobial activity against Streptococcus pneumoniae 02J1175 expressing mef(A) gene by NCCLS method,F,BAO_0002146,BAO_0000218,organism-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1152283,Bioorg Med Chem Lett,2008.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://www.openphacts.org/units/MicrogramPerMilliliter,804105,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
85756,,2380736,CHEMBL944337,Antimicrobial activity against Streptococcus pyogenes Msr 610 expressing erm(B) gene by NCCLS method,F,BAO_0002146,BAO_0000218,organism-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1152283,Bioorg Med Chem Lett,2008.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://www.openphacts.org/units/MicrogramPerMilliliter,804105,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,2.0
85757,,2380742,CHEMBL944338,Antimicrobial activity against linezolid-resistant Enterococcus faecalis P5 by NCCLS method,F,BAO_0002146,BAO_0000218,organism-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1152283,Bioorg Med Chem Lett,2008.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://www.openphacts.org/units/MicrogramPerMilliliter,804105,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,128.0
85758,,2380748,CHEMBL944339,Antimicrobial activity against Haemophilus influenzae RD1 by NCCLS method,F,BAO_0002146,BAO_0000218,organism-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1152283,Bioorg Med Chem Lett,2008.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://www.openphacts.org/units/MicrogramPerMilliliter,804105,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,8.0
85759,,2380754,CHEMBL944334,Antimicrobial activity against Haemophilus influenzae 895 (AcrB-KO) by NCCLS method,F,BAO_0002146,BAO_0000218,organism-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1152283,Bioorg Med Chem Lett,2008.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://www.openphacts.org/units/MicrogramPerMilliliter,804105,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,8.0
85760,Not Active,2589799,CHEMBL965582,Inhibition of bovine brain MAOA,B,BAO_0000375,BAO_0000019,assay format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1152129,J Med Chem,2008.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,,727046,,1,0,,Activity,,,CHEMBL3254,Bos taurus,Monoamine oxidase A,9913.0,,Activity,,,
85761,,3536959,CHEMBL1282284,Inhibition of 50S ribosomal subunit purified from Staphylococcus aureus ATCC 29213 assessed as inhibition of translation using in vitro transcribed mRNA encoding firefly luciferase,B,BAO_0000190,BAO_0000019,assay format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1275513,Antimicrob Agents Chemother,2008.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://www.openphacts.org/units/Nanomolar,971050,<=,1,1,<=,IC50,nM,20.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,0.02
85762,,3536971,CHEMBL1282285,"Inhibition of 50S ribosomal subunit purified from linezolid-,erythromycin-resistant Staphylococcus aureus A7820 with G2576U mutation in 23s rRNA assessed as inhibition of translation using in vitro transcribed mRNA encoding firefly luciferase",B,BAO_0000190,BAO_0000019,assay format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1275513,Antimicrob Agents Chemother,2008.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://www.openphacts.org/units/Nanomolar,971050,<=,1,1,<=,IC50,nM,20.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,0.02
85763,,3536983,CHEMBL1282286,Selectivity ratio of IC50 for rabbit reticulocyte 50S ribosomal subunit to IC50 for Staphylococcus aureus ATCC 29213 50S ribosomal subunit,B,BAO_0000190,BAO_0000019,assay format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL1275513,Antimicrob Agents Chemother,2008.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://www.openphacts.org/units/Nanomolar,971050,=,1,1,=,IC50,nM,7000.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,7.0
85764,,14626522,CHEMBL3258749,Competitive inhibition of peptidyl transferase activity of Escherichia coli ribosome using Ac[14C]-L-Phe-tRNA/puromycin as donor/acceptor substrate assessed as acetyl[14C]phenylalanylpuromycin formation by double reciprocal plot analysis,B,BAO_0000192,BAO_0000019,assay format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL3244100,J Med Chem,1978.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://www.openphacts.org/units/Nanomolar,2093101,=,1,1,=,Ki,nM,500.0,CHEMBL2363135,Bacteria,Bacterial 70S ribosome,2.0,,Ki,uM,UO_0000065,0.5
85765,Active,14628616,CHEMBL3258752,Competitive inhibition of peptidyl transferase activity of Escherichia coli ribosome using Ac[14C]-L-Phe-tRNA/puromycin as donor/acceptor substrate assessed as acetyl[14C]phenylalanylpuromycin formation at 10'-6 M preincubated for 15 mins prior to puromycin addition,B,BAO_0000201,BAO_0000019,assay format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL3244100,J Med Chem,1978.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://qudt.org/vocab/unit#Percent,2093101,,1,0,,Inhibition,%,,CHEMBL2363135,Bacteria,Bacterial 70S ribosome,2.0,,INH,,UO_0000187,
85766,,25092128,CHEMBL5258656,Cytotoxicity against mouse NS-1 cells incubated for 96 hrs by resazurin dye based assay,F,BAO_0002146,BAO_0000219,cell-based format,CSC[S@@+]([O-])CC(CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O,CHEMBL5257063,J Nat Prod,2023.0,CHEMBL2303630,SPARSOMYCIN,CHEMBL2303630,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3934205,=,1,1,=,MIC,ug.mL-1,0.6,CHEMBL612545,,Unchecked,,,MIC,ug ml-1,UO_0000274,0.6
85767,,484630,CHEMBL847261,Enzymatic activity was determined,B,BAO_0000192,BAO_0000019,assay format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL1122594,J Med Chem,1984.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://www.openphacts.org/units/Nanomolar,338304,=,1,1,=,Ki,nM,69000.0,CHEMBL612545,,Unchecked,,,Ki,M,UO_0000065,6.9e-05
85768,,1422193,CHEMBL825419,Antibacterial activity of compound against Bacillus subtilis at 10 ug/mL expressed as zone of inhibition,F,BAO_0003039,BAO_0000218,organism-based format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL1141886,Bioorg Med Chem Lett,2005.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://qudt.org/vocab/unit#Millimeter,365087,=,1,1,=,IZ,mm,11.23,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,Zone of inhibition,mm,UO_0000016,11.23
85769,,1422194,CHEMBL838265,Antibacterial activity of compound against Bacillus subtilis at 20 ug/mL expressed as zone of inhibition,F,BAO_0003039,BAO_0000218,organism-based format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL1141886,Bioorg Med Chem Lett,2005.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://qudt.org/vocab/unit#Millimeter,365087,=,1,1,=,IZ,mm,10.9,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,Zone of inhibition,mm,UO_0000016,10.9
85770,,1422195,CHEMBL838266,Antibacterial activity of compound against Bacillus subtilis at 40 ug/mL expressed as zone of inhibition,F,BAO_0003039,BAO_0000218,organism-based format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL1141886,Bioorg Med Chem Lett,2005.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://qudt.org/vocab/unit#Millimeter,365087,=,1,1,=,IZ,mm,17.9,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,Zone of inhibition,mm,UO_0000016,17.9
85771,,1422196,CHEMBL838267,Antibacterial activity of compound against Bacillus subtilis at 80 ug/mL expressed as zone of inhibition,F,BAO_0003039,BAO_0000218,organism-based format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL1141886,Bioorg Med Chem Lett,2005.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://qudt.org/vocab/unit#Millimeter,365087,=,1,1,=,IZ,mm,21.76,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,Zone of inhibition,mm,UO_0000016,21.76
85772,,1891170,CHEMBL905900,Antibacterial activity against Salmonella enteritidis at 20 mg/ml by paper disc method,F,BAO_0003039,BAO_0000218,organism-based format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL1143789,Bioorg Med Chem Lett,2007.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://qudt.org/vocab/unit#Millimeter,640654,=,1,1,=,IZ,mm,10.0,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,IZ,mm,UO_0000016,10.0
85773,,1891178,CHEMBL905901,Antibacterial activity against Salmonella enteritidis at 30 mg/ml by paper disc method,F,BAO_0003039,BAO_0000218,organism-based format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL1143789,Bioorg Med Chem Lett,2007.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://qudt.org/vocab/unit#Millimeter,640654,=,1,1,=,IZ,mm,15.0,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,IZ,mm,UO_0000016,15.0
85774,,1891186,CHEMBL905902,Antibacterial activity against Salmonella enteritidis at 40 mg/ml by paper disc method,F,BAO_0003039,BAO_0000218,organism-based format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL1143789,Bioorg Med Chem Lett,2007.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://qudt.org/vocab/unit#Millimeter,640654,=,1,1,=,IZ,mm,18.0,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,IZ,mm,UO_0000016,18.0
85775,,1891196,CHEMBL905903,Antibacterial activity against Pasteurella multocida at 20 mg/ml by paper disc method,F,BAO_0003039,BAO_0000218,organism-based format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL1143789,Bioorg Med Chem Lett,2007.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://qudt.org/vocab/unit#Millimeter,640654,=,1,1,=,IZ,mm,20.0,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,IZ,mm,UO_0000016,20.0
85776,,1891207,CHEMBL905904,Antibacterial activity against Pasteurella multocida at 30 mg/ml by paper disc method,F,BAO_0003039,BAO_0000218,organism-based format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL1143789,Bioorg Med Chem Lett,2007.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://qudt.org/vocab/unit#Millimeter,640654,=,1,1,=,IZ,mm,25.0,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,IZ,mm,UO_0000016,25.0
85777,,1891217,CHEMBL905905,Antibacterial activity against Pasteurella multocida at40 mg/ml by paper disc method,F,BAO_0003039,BAO_0000218,organism-based format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL1143789,Bioorg Med Chem Lett,2007.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://qudt.org/vocab/unit#Millimeter,640654,=,1,1,=,IZ,mm,25.0,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,IZ,mm,UO_0000016,25.0
85778,Inconclusive,4636527,CHEMBL1614530,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",F,BAO_0000186,BAO_0000019,assay format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL1201862,,,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://www.openphacts.org/units/Nanomolar,1298336,=,7,1,=,Potency,nM,6309.6,CHEMBL2026,Escherichia coli K-12,Beta-lactamase AmpC,83333.0,,Potency,um,UO_0000065,6.3096
85779,inconclusive,10297997,CHEMBL1963912,PUBCHEM_BIOASSAY: S16 Schwann cell viability assay (CellTiter-Glo assay). (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000219,cell-based format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL1201862,,,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://www.openphacts.org/units/Nanomolar,977812,,7,1,,Potency,nM,3463.7,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,3.4637
85780,inactive,14180822,CHEMBL3215181,PubChem BioAssay. qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen.   (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL1201862,,,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://www.openphacts.org/units/Nanomolar,1298336,,7,1,,Potency,nM,3162.3,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,3.1623
85781,inconclusive,14457631,CHEMBL3214970,PubChem BioAssay. qHTS Assay for Identifying Gametocytocidal Compounds.   (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL1201862,,,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://www.openphacts.org/units/Nanomolar,2033033,,7,1,,Potency,nM,3162.3,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,3.1623
85782,inactive,15597062,CHEMBL3562136,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel.   (Class of assay: confirmatory) ",F,BAO_0000186,BAO_0000019,assay format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL1201862,,,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://www.openphacts.org/units/Nanomolar,2474607,,7,1,,AC50,nM,2238.7,CHEMBL612545,,Unchecked,,,AC50,uM,UO_0000065,2.2387
85783,inactive,15597827,CHEMBL3562146,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel.   (Class of assay: confirmatory) ",F,BAO_0000186,BAO_0000019,assay format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL1201862,,,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://www.openphacts.org/units/Nanomolar,2474607,,7,1,,AC50,nM,2511.9,CHEMBL612545,,Unchecked,,,AC50,uM,UO_0000065,2.5119
85784,,18830526,CHEMBL4303805,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL4303101,,2020.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://qudt.org/vocab/unit#Percent,3137024,=,52,1,=,Inhibition,%,0.82,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,Inhibition,%,UO_0000187,0.82
85785,,19961689,CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate,F,BAO_0000201,BAO_0000019,assay format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL4495564,,2020.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://qudt.org/vocab/unit#Percent,3348107,=,52,1,=,Inhibition,%,3.169,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,Inhibition,%,UO_0000187,3.168724955
85786,,20149016,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL4495565,,2020.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://qudt.org/vocab/unit#Percent,3365979,=,52,1,=,Inhibition,%,-0.06,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,-0.06
85787,,22077469,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL4495565,,2020.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://qudt.org/vocab/unit#Percent,3365979,=,52,1,=,Inhibition,%,-0.06,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,-0.06
85788,No. Measurements = 1,22083704,CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000190,BAO_0000218,organism-based format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL4651402,,2021.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://www.openphacts.org/units/Nanomolar,3490681,>,57,1,>,IC50,nM,20000.0,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,IC50,M,UO_0000065,2e-05
85789,No. Measurements = 1,22083705,CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000190,BAO_0000218,organism-based format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL4651402,,2021.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://www.openphacts.org/units/Nanomolar,3490681,<,57,1,>,IC50,nM,19952.62,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,pIC50,,UO_0000065,4.7
85790,Not Active,22433338,CHEMBL4677092,Inhibition of RNAi in human Hela cells expressing Renilla/firefly luciferase genes and siRNA assessed as siRNA-mediated gene silencing activity at 100 to 500 nM by dual luciferase assay relative to control,B,BAO_0000201,BAO_0000219,cell-based format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL4673266,Bioorg Med Chem Lett,2020.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://qudt.org/vocab/unit#Percent,3515262,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
85791,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25207876,CHEMBL5291800,Binding affinity towards rat Gabra1 in an in vitro assay with cellular components measured by scintillation counting,B,BAO_0000186,BAO_0000357,single protein format,N=C(N)NS(=O)(=O)c1ccc(N)cc1,CHEMBL5291721,Nat Commun,2023.0,CHEMBL338802,SULFAGUANIDINE,CHEMBL338802,0,http://www.openphacts.org/units/Nanomolar,3941096,>,1,1,>,AC50,nM,30000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,AC50,uM,UO_0000065,30.0
85792,,504487,CHEMBL810855,In Vitro minimal inhibitory concentration against Staphylococcus aureus (FDA 209P),F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1131185,J Med Chem,1998.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,276236,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.4
85793,,504488,CHEMBL677714,In Vitro minimal inhibitory concentration against Escherichia coli (ATCC 39188),F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1131185,J Med Chem,1998.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,276236,=,1,1,=,MIC,ug.mL-1,2.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.3
85794,,504489,CHEMBL799648,In Vitro minimal inhibitory concentration against Salmonella typhi (O-901),F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1131185,J Med Chem,1998.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,276236,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC,ug ml-1,UO_0000274,128.0
85795,,504490,CHEMBL766020,In Vitro minimal inhibitory concentration against Pseudomonas aeruginosa (1101-75),F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1131185,J Med Chem,1998.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,276236,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
85796,,504491,CHEMBL701617,In Vitro minimal inhibitory concentration against Klebsiella pneumoniae (NCTC 418),F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1131185,J Med Chem,1998.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,276236,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,128.0
85797,,675425,CHEMBL774707,Concentration of compound in rat brain after intravenous injection of 20 mg/kg benzyl-penicillin after 1 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,2.7,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,2.7
85798,,675426,CHEMBL774712,Concentration of compound in rat brain after intravenous injection of 20 mg/kg benzyl-penicillin after 3 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,1.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,1.3
85799,,675427,CHEMBL774716,Concentration of compound in rat brain after intravenous injection of 20 mg/kg benzyl-penicillin after 5 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,0.9,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,0.9
85800,,675428,CHEMBL774708,Concentration of compound in rat brain after intravenous injection of 20 mg/kg benzyl-penicillin after 10 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,0.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,0.3
85801,Below detection limit,675429,CHEMBL774710,Concentration of compound in rat brain after intravenous injection of 20 mg/kg benzyl-penicillin after 20 min; Below detection limit.,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,85039,,1,0,,Concentration,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,,
85802,Below detection limit,675430,CHEMBL774714,Concentration of compound in rat brain after intravenous injection of 20 mg/kg benzyl-penicillin after 40 min; Below detection limit.,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,85039,,1,0,,Concentration,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,,
85803,Below detection limit,675431,CHEMBL773829,Concentration of compound in rat brain after intravenous injection of 20 mg/kg benzyl-penicillin after 60 min; Below detection limit.,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,85039,,1,0,,Concentration,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,,
85804,,675432,CHEMBL774700,Concentration of compound in rat blood after intravenous injection of 20 mg/kg benzyl-penicillin after 1 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,64.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,64.6
85805,,675433,CHEMBL774703,Concentration of compound in rat blood after intravenous injection of 20 mg/kg benzyl-penicillin after 3 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,25.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,25.2
85806,,675434,CHEMBL774705,Concentration of compound in rat blood after intravenous injection of 20 mg/kg benzyl-penicillin after 5 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,22.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,22.8
85807,,675435,CHEMBL774701,Concentration of compound in rat blood after intravenous injection of 20 mg/kg benzyl-penicillin after 10 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,8.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,8.5
85808,,675436,CHEMBL774702,Concentration of compound in rat blood after intravenous injection of 20 mg/kg benzyl-penicillin after 20 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,2.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,2.8
85809,,675437,CHEMBL774704,Concentration of compound in rat blood after intravenous injection of 20 mg/kg benzyl-penicillin after 40 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,1.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,1.3
85810,,675438,CHEMBL774706,Concentration of compound in rat blood after intravenous injection of 20 mg/kg benzyl-penicillin after 60 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,0.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,0.4
85811,,675439,CHEMBL773831,Concentration of compound in rat kidney after intravenous injection of 20 mg/kg benzyl-penicillin after 1 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,33.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,33.6
85812,,675440,CHEMBL773834,Concentration of compound in rat kidney after intravenous injection of 20 mg/kg benzyl-penicillin after 3 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,120.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,120.5
85813,,675441,CHEMBL773836,Concentration of compound in rat kidney after intravenous injection of 20 mg/kg benzyl-penicillin after 5 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,88.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,88.5
85814,,675442,CHEMBL773838,Concentration of compound in rat kidney after intravenous injection of 20 mg/kg benzyl-penicillin after 10 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,27.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,27.6
85815,,675443,CHEMBL773833,Concentration of compound in rat kidney after intravenous injection of 20 mg/kg benzyl-penicillin after 20 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,20.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,20.8
85816,,675444,CHEMBL773835,Concentration of compound in rat kidney after intravenous injection of 20 mg/kg benzyl-penicillin after 40 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,6.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,6.2
85817,,675445,CHEMBL773837,Concentration of compound in rat kidney after intravenous injection of 20 mg/kg benzyl-penicillin after 60 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,1.1,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,1.1
85818,,675446,CHEMBL773839,Concentration of compound in rat liver after intravenous injection of 20 mg/kg benzyl-penicillin after 1 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,15.1,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,15.1
85819,,675447,CHEMBL773842,Concentration of compound in rat liver after intravenous injection of 20 mg/kg benzyl-penicillin after 3 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,38.9,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,38.9
85820,,675448,CHEMBL773844,Concentration of compound in rat liver after intravenous injection of 20 mg/kg benzyl-penicillin after 5 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,30.7,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,30.7
85821,,675449,CHEMBL773840,Concentration of compound in rat liver after intravenous injection of 20 mg/kg benzyl-penicillin after 10 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,17.7,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,17.7
85822,,675450,CHEMBL773841,Concentration of compound in rat liver after intravenous injection of 20 mg/kg benzyl-penicillin after 20 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,7.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,7.5
85823,,675451,CHEMBL773843,Concentration of compound in rat liver after intravenous injection of 20 mg/kg benzyl-penicillin after 40 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,2.9,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,2.9
85824,,675452,CHEMBL777016,Concentration of compound in rat liver after intravenous injection of 20 mg/kg benzyl-penicillin after 60 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,0.7,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,0.7
85825,,675453,CHEMBL777017,Concentration of compound in rat lung after intravenous injection of 20 mg/kg benzyl-penicillin after 1 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,52.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,52.5
85826,,675454,CHEMBL777020,Concentration of compound in rat lung after intravenous injection of 20 mg/kg benzyl-penicillin after 3 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,30.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,30.3
85827,,675455,CHEMBL777022,Concentration of compound in rat lung after intravenous injection of 20 mg/kg benzyl-penicillin after 5 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,22.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,22.4
85828,,675456,CHEMBL777018,Concentration of compound in rat lung after intravenous injection of 20 mg/kg benzyl-penicillin after 10 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,9.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,9.5
85829,,675457,CHEMBL777019,Concentration of compound in rat lung after intravenous injection of 20 mg/kg benzyl-penicillin after 20 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,2.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,2.3
85830,,675458,CHEMBL777021,Concentration of compound in rat lung after intravenous injection of 20 mg/kg benzyl-penicillin after 40 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,1.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,1.4
85831,,675459,CHEMBL777023,Concentration of compound in rat lung after intravenous injection of 20 mg/kg benzyl-penicillin after 60 min,F,BAO_0002752,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124553,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,85039,=,1,0,=,Concentration,ug ml-1,0.7,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Concentration,ug ml-1,UO_0000274,0.7
85832,,739646,CHEMBL762881,Concentration required for 90 percent inhibition of [14C]- pen-G binding to Escherichia coli DCO PBP1a 90 KDa,B,BAO_0002752,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1151601,Bioorg Med Chem Lett,1993.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,135295,>,1,0,>,Concentration,ug ml-1,100.0,CHEMBL612545,,Unchecked,,,Concentration,ug ml-1,UO_0000274,100.0
85833,,739647,CHEMBL762882,Concentration required for 90 percent inhibition of [14C]- pen-G binding to Escherichia coli DCO PBP1b 90 KDa,B,BAO_0002752,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1151601,Bioorg Med Chem Lett,1993.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,135295,=,1,0,=,Concentration,ug ml-1,10.0,CHEMBL612545,,Unchecked,,,Concentration,ug ml-1,UO_0000274,10.0
85834,,739648,CHEMBL762883,Concentration required for 90 percent inhibition of [14C]- pen-G binding to Escherichia coli DCO PBP2 66 KDa,B,BAO_0002752,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1151601,Bioorg Med Chem Lett,1993.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,135295,=,1,0,=,Concentration,ug ml-1,10.0,CHEMBL612545,,Unchecked,,,Concentration,ug ml-1,UO_0000274,10.0
85835,,739649,CHEMBL762884,Concentration required for 90 percent inhibition of [14C]- pen-G binding to Escherichia coli DCO PBP3 60 KDa,B,BAO_0002752,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1151601,Bioorg Med Chem Lett,1993.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,135295,=,1,0,=,Concentration,ug ml-1,2.0,CHEMBL612545,,Unchecked,,,Concentration,ug ml-1,UO_0000274,2.0
85836,,739650,CHEMBL762885,Concentration required for 90 percent inhibition of [14C]- pen-G binding to Escherichia coli DCO PBP4 49 KDa,B,BAO_0002752,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1151601,Bioorg Med Chem Lett,1993.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,135295,=,1,0,=,Concentration,ug ml-1,2.0,CHEMBL612545,,Unchecked,,,Concentration,ug ml-1,UO_0000274,2.0
85837,,739651,CHEMBL762886,Concentration required for 90 percent inhibition of [14C]- pen-G binding to Escherichia coli DCO PBP5/6 40 KDa,B,BAO_0002752,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1151601,Bioorg Med Chem Lett,1993.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,135295,>,1,0,>,Concentration,ug ml-1,100.0,CHEMBL612545,,Unchecked,,,Concentration,ug ml-1,UO_0000274,100.0
85838,,739652,CHEMBL682920,Tested for minimum inhibitory concentration against Escherichia coli DCO,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1151601,Bioorg Med Chem Lett,1993.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,135295,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,50.0
85839,,739653,CHEMBL682918,Tested for minimum inhibitory concentration against Escherichia coli DC2,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1151601,Bioorg Med Chem Lett,1993.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,135295,=,1,1,=,MIC,ug.mL-1,12.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,12.0
85840,,739654,CHEMBL882311,Concentration required for 90 percent inhibition of [14C]- pen-G binding to Staphylococcus aureus ATCC 25293 PBP1 87 KDa,B,BAO_0002752,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1151601,Bioorg Med Chem Lett,1993.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,135295,=,1,0,=,Concentration,ug ml-1,0.1,CHEMBL612545,,Unchecked,,,Concentration,ug ml-1,UO_0000274,0.1
85841,,739655,CHEMBL762887,Concentration required for 90 percent inhibition of [14C]- pen-G binding to Staphylococcus aureus ATCC 25293 PBP2 80 KDa,B,BAO_0002752,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1151601,Bioorg Med Chem Lett,1993.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,135295,=,1,0,=,Concentration,ug ml-1,0.1,CHEMBL612545,,Unchecked,,,Concentration,ug ml-1,UO_0000274,0.1
85842,,739656,CHEMBL762888,Concentration required for 90 percent inhibition of [14C]- pen-G binding to Staphylococcus aureus ATCC 25293 PBP3 75 KDa,B,BAO_0002752,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1151601,Bioorg Med Chem Lett,1993.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,135295,=,1,0,=,Concentration,ug ml-1,0.1,CHEMBL612545,,Unchecked,,,Concentration,ug ml-1,UO_0000274,0.1
85843,,739657,CHEMBL762889,Concentration required for 90 percent inhibition of [14C]- pen-G binding to Staphylococcus aureus ATCC 25293 PBP4 41 KDa,B,BAO_0002752,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1151601,Bioorg Med Chem Lett,1993.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,135295,=,1,0,=,Concentration,ug ml-1,10.0,CHEMBL612545,,Unchecked,,,Concentration,ug ml-1,UO_0000274,10.0
85844,,739658,CHEMBL808061,Tested for minimum inhibitory concentration against Staphylococcus aureus ATCC 25293,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1151601,Bioorg Med Chem Lett,1993.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,135295,<,1,1,<,MIC,ug.mL-1,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.05
85845,,748912,CHEMBL810377,"In vitro antibacterial activity against the gram-positive bacteria, penicillin sensitive Staphylococcus aureus (663E)",F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1132087,Bioorg Med Chem Lett,1999.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,4561,<,1,1,<,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85846,,748913,CHEMBL810376,"In vitro antibacterial activity against the gram-positive bacteria, penicillin sensitive Staphylococcus aureus (3072)",F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1132087,Bioorg Med Chem Lett,1999.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,4561,<,1,1,<,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85847,,748914,CHEMBL883635,"In vitro antibacterial activity against the gram-positive bacteria, penicillin sensitive Staphylococcus aureus (3849)",F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1132087,Bioorg Med Chem Lett,1999.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,4561,<,1,1,<,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
85848,,748915,CHEMBL810375,"In vitro antibacterial activity against the gram-positive bacteria, penicillin resistant Staphylococcus aureus (853)",F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1132087,Bioorg Med Chem Lett,1999.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,4561,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
85849,,748916,CHEMBL810374,"In vitro antibacterial activity against the gram-positive bacteria, penicillin resistant Staphylococcus aureus (2672)",F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1132087,Bioorg Med Chem Lett,1999.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,4561,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
85850,,748917,CHEMBL810373,"In vitro antibacterial activity against the gram-positive bacteria, penicillin resistant Staphylococcus aureus (2619)",F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1132087,Bioorg Med Chem Lett,1999.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,4561,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
85851,,748918,CHEMBL808405,"In vitro antibacterial activity against the gram-positive bacteria, penicillin sensitive Streptococcus pneumoniae (3512)",F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1132087,Bioorg Med Chem Lett,1999.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,4561,<,1,1,<,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
85852,,748919,CHEMBL883485,"In vitro antibacterial activity against the gram-positive bacteria, penicillin sensitive Streptococcus pneumoniae (3272)",F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1132087,Bioorg Med Chem Lett,1999.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,4561,<,1,1,<,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
85853,,748920,CHEMBL808404,"In vitro antibacterial activity against the gram-positive bacteria, penicillin sensitive Streptococcus pneumoniae (3273)",F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1132087,Bioorg Med Chem Lett,1999.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,4561,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
85854,,748921,CHEMBL808400,"In vitro antibacterial activity against the gram-positive bacteria, penicillin resistant Streptococcus pneumoniae (4629)",F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1132087,Bioorg Med Chem Lett,1999.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,4561,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
85855,,748922,CHEMBL808401,"In vitro antibacterial activity against the gram-positive bacteria, penicillin resistant Streptococcus pneumoniae (4630)",F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1132087,Bioorg Med Chem Lett,1999.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,4561,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
85856,,748923,CHEMBL808402,"In vitro antibacterial activity against the gram-positive bacteria, penicillin resistant Streptococcus pneumoniae (4635)",F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1132087,Bioorg Med Chem Lett,1999.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,4561,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
85857,,748924,CHEMBL808403,"In vitro antibacterial activity against the gram-positive bacteria, penicillin resistant Streptococcus pneumoniae (4636)",F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1132087,Bioorg Med Chem Lett,1999.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,4561,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
85858,Not Determined,748925,CHEMBL814800,"In vitro antibacterial activity against the gram-positive bacteria, erythromycin resistant Streptococcus pyogenes; Not determined",F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1132087,Bioorg Med Chem Lett,1999.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,4561,,1,0,,MIC,ug.mL-1,,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,
85859,,788763,CHEMBL809182,Minimum inhibitory concentration against aerobic organism Streptococcus pyogenes strain 3124,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1122046,J Med Chem,1982.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,276449,<,1,1,<,MIC,ug.mL-1,0.39,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.39
85860,,788764,CHEMBL814015,Minimum inhibitory concentration against aerobic organisms Streptococcus faecalis strain 2864,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1122046,J Med Chem,1982.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,276449,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.56
85861,,788765,CHEMBL812132,Minimum inhibitory concentration against aerobic organism Staphylococcus aureus strain 2868,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1122046,J Med Chem,1982.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,276449,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,12.5
85862,,788766,CHEMBL674607,MIC against aerobic organism Escherichia coli strain 2891,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1122046,J Med Chem,1982.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,276449,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,100.0
85863,,788767,CHEMBL858055,Minimum inhibitory concentration against aerobic organism Shigella species strain 2880,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1122046,J Med Chem,1982.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,276449,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL614397,Shigella sp.,Shigella sp.,625.0,,MIC,ug ml-1,UO_0000274,6.25
85864,,788768,CHEMBL802166,Minimum inhibitory concentration against aerobic organism Salmonella schottmuelleri 2837,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1122046,J Med Chem,1982.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,276449,=,1,1,=,MIC,ug.mL-1,3.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,3.12
85865,,788769,CHEMBL700809,Minimum inhibitory concentration against aerobic organism Klebsiella pneumoniae strain 2882,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1122046,J Med Chem,1982.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,276449,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,25.0
85866,,788770,CHEMBL682416,Minimum inhibitory concentration against aerobic organism Enterobacter cloacae 2646,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1122046,J Med Chem,1982.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,276449,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,100.0
85867,,864747,CHEMBL811500,In vitro antimicrobial activity against Staphylococcus aureus FDA 209P was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1133014,J Med Chem,2000.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,229841,=,1,1,=,MIC,ug.mL-1,0.51,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.51
85868,,864748,CHEMBL808690,In vitro antimicrobial activity against Staphylococcus aureus 95 (methicillin-resistant strain) was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1133014,J Med Chem,2000.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,229841,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
85869,,864749,CHEMBL673564,In vitro antimicrobial activity against Escherichia coli ATCC 39188 was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1133014,J Med Chem,2000.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,229841,=,1,1,=,MIC,ug.mL-1,2.87,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.87
85870,,864750,CHEMBL703022,In vitro antimicrobial activity against Klebsiella pneumoniae NCTC 418 was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1133014,J Med Chem,2000.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,229841,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,128.0
85871,,864751,CHEMBL771128,In vitro antimicrobial activity against Pseudomonas aeruginosa 1101-75 was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1133014,J Med Chem,2000.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,229841,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
85872,,864752,CHEMBL764217,In vitro antimicrobial activity against Pseudomonas aeruginosa 18S-H was determined,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1133014,J Med Chem,2000.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,229841,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
85873,,864753,CHEMBL823329,In vitro antimicrobial activity against Xanthomonas maltophilia GN 12873 was determined,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1133014,J Med Chem,2000.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,229841,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL612545,,Unchecked,,,MIC,ug ml-1,UO_0000274,128.0
85874,,864754,CHEMBL808691,Minimum protective concentration against beta-lactamase of Staphylococcus aureus 95,F,BAO_0000179,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1133014,J Med Chem,2000.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,229841,=,1,0,=,MPC,ug ml-1,1.85,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MPC,ug ml-1,UO_0000274,1.85
85875,,864755,CHEMBL764218,Minimum protective concentration against beta-lactamase of Pseudomonas aeruginosa 18S-H,F,BAO_0000179,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1133014,J Med Chem,2000.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,229841,=,1,0,=,MPC,ug ml-1,1.03,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MPC,ug ml-1,UO_0000274,1.03
85876,,864756,CHEMBL823330,Minimum protective concentration against beta-lactamase of Xanthomonas maltophilia GN 12873 (CXase-I),F,BAO_0000179,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1133014,J Med Chem,2000.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,229841,=,1,0,=,MPC,ug ml-1,23.56,CHEMBL3879801,,NON-PROTEIN TARGET,,,MPC,ug ml-1,UO_0000274,23.56
85877,,864757,CHEMBL823331,Minimum protective concentration against beta-lactamase of Xanthomonas maltophilia GN 12873 (CXase-II),F,BAO_0000179,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1133014,J Med Chem,2000.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,229841,=,1,0,=,MPC,ug ml-1,28.84,CHEMBL3879801,,NON-PROTEIN TARGET,,,MPC,ug ml-1,UO_0000274,28.84
85878,,949976,CHEMBL809337,Antibacterial activity was determined against clinically isolated penicillin resistant Streptococcus pneumoniae (PRSP) strains (50 strains); Range= 1-4,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1145781,J Med Chem,2003.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1763,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
85879,,1045490,CHEMBL858080,Compound was evaluated for the antibacterial activity against Staphylococcus aureus with the strain 209P,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1122575,J Med Chem,1984.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,152159,=,1,1,=,MIC,ug.mL-1,0.065,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.065
85880,,1045491,CHEMBL814299,Compound was evaluated for the antibacterial activity against Staphylococcus aureus with the strains beta-Lactamase-positive (LAC+)/ beta-Lactamase-negative (LAC-); 64/0.03,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1122575,J Med Chem,1984.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,152159,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
85881,,1045492,CHEMBL857290,Stability against beta-lactamase of Staphylococcus aureus,B,BAO_0000477,BAO_0000357,single protein format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1122575,J Med Chem,1984.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/Nanomolar,152159,=,1,1,=,Km,nM,12000.0,CHEMBL4114,Staphylococcus aureus,Beta-lactamase,1280.0,,Km,uM,UO_0000065,12.0
85882,,1114108,CHEMBL639330,Hydrolysis half life using immobilized penicillin-G acylase,A,BAO_0002115,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1127994,Bioorg Med Chem Lett,1994.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://qudt.org/vocab/unit#Hour,220861,=,1,1,=,T1/2,hr,0.4167,CHEMBL612558,,ADMET,,,T1/2,min,UO_0000032,25.0
85883,,1151004,CHEMBL653603,Inhibition constant (Ki) for TEM-1 beta-lactamase,B,BAO_0000192,BAO_0000357,single protein format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124033,J Med Chem,1988.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/Nanomolar,234415,=,1,1,=,Ki,nM,20000.0,CHEMBL2065,Escherichia coli,Beta-lactamase TEM,562.0,,Ki,uM,UO_0000065,20.0
85884,,1192707,CHEMBL681199,Inhibition of gram positive bacteria growth.,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124506,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45667,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL612545,,Unchecked,,,MIC,ug ml-1,UO_0000274,0.05
85885,,1192708,CHEMBL682533,Inhibition of gram positive (resistant) bacteria growth.,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124506,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45667,=,1,1,=,MIC,ug.mL-1,79.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,79.0
85886,,1192709,CHEMBL681725,Inhibition of gram negative bacteria growth.,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124506,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45667,=,1,1,=,MIC,ug.mL-1,71.0,CHEMBL612545,,Unchecked,,,MIC,ug ml-1,UO_0000274,71.0
85887,,1192710,CHEMBL681198,Inhibition of gram negative (resistant) growth.,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1124506,J Med Chem,1989.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,45667,>,1,1,>,MIC,ug.mL-1,200.0,CHEMBL612545,,Unchecked,,,MIC,ug ml-1,UO_0000274,200.0
85888,,1302009,CHEMBL809922,In vitro Minimum inhibitory concentration against Staphylococcus aureus ATCC 6538P (penicillin G sensitive),F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1121733,J Med Chem,1981.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29837,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.05
85889,,1302010,CHEMBL806107,In vitro Minimum inhibitory concentration against Staphylococcus penicillin G resistant),F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1121733,J Med Chem,1981.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29837,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,50.0
85890,,1302011,CHEMBL811309,In vitro Minimum inhibitory concentration against Streptococcus faecium ATCC 8043-2,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1121733,J Med Chem,1981.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29837,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.4
85891,,1302012,CHEMBL811012,In vitro Minimum inhibitory concentration against Streptococcus pyogenes ATCC 8668,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1121733,J Med Chem,1981.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29837,=,1,1,=,MIC,ug.mL-1,0.01,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.01
85892,,1302013,CHEMBL677716,In vitro Minimum inhibitory concentration against Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1121733,J Med Chem,1981.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29837,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,25.0
85893,,1406277,CHEMBL829429,Binding affinity for TEM-1 beta-lactamase,B,BAO_0000477,BAO_0000357,single protein format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1145182,J Med Chem,2005.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/Nanomolar,361504,=,1,1,=,Km,nM,75000.0,CHEMBL2065,Escherichia coli,Beta-lactamase TEM,562.0,,Km,uM,UO_0000065,75.0
85894,,1439287,CHEMBL836066,Minimum inhibitory concentration against Bacillus subtilis (Gram-positive) was determined by by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1141068,Bioorg Med Chem Lett,2005.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,371320,=,1,1,=,MIC,ug.mL-1,1.562,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,1.562
85895,,1439288,CHEMBL836065,Minimum inhibitory concentration against Bacillus sphaericus (Gram-positive) was determined by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1141068,Bioorg Med Chem Lett,2005.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,371320,=,1,1,=,MIC,ug.mL-1,3.125,CHEMBL614956,Bacillus sp.,Bacillus sp.,1409.0,,MIC,ug ml-1,UO_0000274,3.125
85896,,1439289,CHEMBL836083,Minimum inhibitory concentration against Staphylococcus aureus (Gram-positive) was determined by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1141068,Bioorg Med Chem Lett,2005.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,371320,=,1,1,=,MIC,ug.mL-1,1.562,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.562
85897,,1439290,CHEMBL830580,Minimum inhibitory concentration against Chromobacterium violaceum (Gram-negative) was determined by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1141068,Bioorg Med Chem Lett,2005.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,371320,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,12.5
85898,,1439560,CHEMBL830615,Minimum inhibitory concentration against Klebsiella aerogenes (Gram-negative) in broth,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1141068,Bioorg Med Chem Lett,2005.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,371320,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,6.25
85899,,1439561,CHEMBL835101,Minimum inhibitory concentration against Pseudomonas aeruginosa (Gram-negative) by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1141068,Bioorg Med Chem Lett,2005.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,371320,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,12.5
85900,,1664529,CHEMBL863417,Antibacterial activity against gram positive Bacillus subtilis MTCC 441,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1148560,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,416740,=,1,1,=,MIC,ug.mL-1,1.562,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,1.562
85901,,1664544,CHEMBL863418,Antibacterial activity against gram positive Bacillus sphaericus (MTCC 11),F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1148560,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,416740,=,1,1,=,MIC,ug.mL-1,3.125,CHEMBL613863,Lysinibacillus sphaericus,Lysinibacillus sphaericus,1421.0,,MIC,ug ml-1,UO_0000274,3.125
85902,,1664559,CHEMBL863419,Antibacterial activity against gram positive Staphylococcus aureus(MTCC 96),F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1148560,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,416740,=,1,1,=,MIC,ug.mL-1,1.562,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.562
85903,,1664574,CHEMBL863421,Antibacterial activity against gram negative Klebsiella aerogenes(MTCC 39),F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1148560,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,416740,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,6.25
85904,,1664589,CHEMBL863422,Antibacterial activity against gram negative Chromobacterium violaceum(MTCC 2656),F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1148560,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,416740,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL613862,Chromobacterium violaceum,Chromobacterium violaceum,536.0,,MIC,ug ml-1,UO_0000274,12.5
85905,,1664604,CHEMBL863420,Antibacterial activity against gram negative Pseudomonas aeruginosa (MTCC 741),F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1148560,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,416740,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,6.25
85906,,1705738,CHEMBL866608,Antibacterial activity against Staphylococcus aureus 849 ATCC 25923 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146116,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/Millimolar,451437,=,1,0,=,IZ,mM,33.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mM,UO_0000063,33.0
85907,,1705768,CHEMBL869590,Antibacterial activity against methicillin-resistant Staphylococcus aureus USF652 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146116,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/Millimolar,451437,=,1,0,=,IZ,mM,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mM,UO_0000063,8.0
85908,,1705781,CHEMBL868445,Antibacterial activity against methicillin-resistant Staphylococcus aureus USF653 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146116,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/Millimolar,451437,=,1,0,=,IZ,mM,15.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mM,UO_0000063,15.0
85909,,1705791,CHEMBL868446,Antibacterial activity against methicillin-resistant Staphylococcus aureus USF654 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146116,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/Millimolar,451437,=,1,0,=,IZ,mM,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mM,UO_0000063,10.0
85910,,1705801,CHEMBL868447,Antibacterial activity against methicillin-resistant Staphylococcus aureus USF655 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146116,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/Millimolar,451437,=,1,0,=,IZ,mM,14.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mM,UO_0000063,14.0
85911,,1705812,CHEMBL868448,Antibacterial activity against methicillin-resistant Staphylococcus aureus USF656 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146116,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/Millimolar,451437,=,1,0,=,IZ,mM,12.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mM,UO_0000063,12.0
85912,,1705823,CHEMBL868449,Antibacterial activity against methicillin-resistant Staphylococcus aureus USF657 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146116,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/Millimolar,451437,=,1,0,=,IZ,mM,12.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mM,UO_0000063,12.0
85913,,1705834,CHEMBL868450,Antibacterial activity against methicillin-resistant Staphylococcus aureus USF658 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146116,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/Millimolar,451437,=,1,0,=,IZ,mM,19.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mM,UO_0000063,19.0
85914,,1705845,CHEMBL868451,Antibacterial activity against methicillin-resistant Staphylococcus aureus USF659 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146116,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/Millimolar,451437,=,1,0,=,IZ,mM,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mM,UO_0000063,16.0
85915,Not Determined,1757631,CHEMBL870346,Antibacterial activity against MRSA Staphylococcus aureus 134/93 by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,541899,,1,0,,IZ,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,,,
85916,Not Determined,1757633,CHEMBL870347,Antibacterial activity against VRE Enterococcus faecalis 1528 by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,541899,,1,0,,IZ,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,IZ,,,
85917,Not Determined,1757635,CHEMBL853421,Antibacterial activity against wild type Mycobacterium vaccae IMET10670 by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,541899,,1,0,,IZ,,,CHEMBL614981,Mycobacterium,Mycobacterium,1763.0,,IZ,,,
85918,Not Determined,1757637,CHEMBL853424,Antibacterial activity against wild type Escherichia coli DC0 by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,541899,,1,0,,IZ,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,,,
85919,Not Determined,1757639,CHEMBL853425,Antibacterial activity against TEM1 beta-lactamase Escherichia coli IV-3-2 by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,541899,,1,0,,IZ,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,,,
85920,Not Determined,1757641,CHEMBL853426,Antibacterial activity against ampC beta-lactamase Enterobacter cloacae P99 by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,541899,,1,0,,IZ,,,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,IZ,,,
85921,Not Determined,1757643,CHEMBL853427,Antibacterial activity against PSE1 beta-lactamase Pseudomonas aeruginosa IV-3-13 by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,541899,,1,0,,IZ,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IZ,,,
85922,,1757645,CHEMBL853428,Antibacterial activity against Escherichia coli X580 by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://qudt.org/vocab/unit#Millimeter,541899,=,1,1,=,IZ,mm,54.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,54.0
85923,,1757647,CHEMBL853429,Antibacterial activity against Escherichia coli ATCC 33475 by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://qudt.org/vocab/unit#Millimeter,541899,=,1,1,=,IZ,mm,23.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,23.0
85924,,1757649,CHEMBL853430,Antibacterial activity against Salmonella enterica ATCC 13311 by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://qudt.org/vocab/unit#Millimeter,541899,=,1,1,=,IZ,mm,37.0,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,IZ,mm,UO_0000016,37.0
85925,,1757651,CHEMBL853431,Antibacterial activity against Klebsiella pneumoniae ATCC 8308 by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://qudt.org/vocab/unit#Millimeter,541899,=,1,1,=,IZ,mm,12.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,IZ,mm,UO_0000016,12.0
85926,Not Determined,1757653,CHEMBL853432,Antifungal activity against Candida albicans BMSY 212 by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,541899,,1,0,,IZ,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,IZ,,,
85927,Not Determined,1757683,CHEMBL870345,Antibacterial activity against wild type Staphylococcus aureus SG 511 by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146029,Bioorg Med Chem Lett,2006.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,541899,,1,0,,IZ,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,,,
85928,,1800303,CHEMBL911667,Antibacterial activity against Pseudomonas aeruginosa IAM1058,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1139213,J Nat Prod,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,620882,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
85929,,1819122,CHEMBL908583,Antibacterial activity against Streptococcus pyogenes M12 by time-kill curve assay,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142144,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625623,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,mg/L,UO_0000274,0.012
85930,,1828456,CHEMBL854623,Antibacterial activity against Enterococcus faecalis isolate 5744,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625688,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
85931,,1828464,CHEMBL854624,Antibacterial activity against Enterococcus faecalis isolate 5743,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625688,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
85932,,1828473,CHEMBL854625,Antibacterial activity against Enterococcus faecalis isolate 5742,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625688,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
85933,,1828481,CHEMBL854626,Antibacterial activity against Enterococcus faecium isolate 2547,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625688,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,128.0
85934,,1828488,CHEMBL854627,Antibacterial activity against Enterococcus faecium isolate 5749,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625688,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,128.0
85935,,1828496,CHEMBL854628,Antibacterial activity against Enterococcus faecium isolate 5750,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625688,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,256.0
85936,,1828504,CHEMBL854629,Antibacterial activity against Enterococcus faecium isolate 5751,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625688,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,256.0
85937,,1828511,CHEMBL854630,Antibacterial activity against Enterococcus faecium isolate 5752,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625688,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,128.0
85938,,1828518,CHEMBL854631,Antibacterial activity against Enterococcus faecium isolate 5753,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625688,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,256.0
85939,,1828525,CHEMBL854632,Antibacterial activity against Enterococcus faecalis isolate 5745,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625688,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
85940,,1828532,CHEMBL854633,Antibacterial activity against Enterococcus faecalis isolate 5746,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625688,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
85941,Not Evaluated,1829186,CHEMBL909765,Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs,F,BAO_0000375,BAO_0000219,cell-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,625745,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
85942,Not Evaluated,1829187,CHEMBL909766,Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs,F,BAO_0000375,BAO_0000219,cell-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,625745,,1,0,,Activity,,,CHEMBL612582,,Osteoblast,,,Activity,,,
85943,,1829505,CHEMBL910963,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae,F,BAO_0003035,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142169,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625786,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,2.0
85944,,1829506,CHEMBL910963,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae,F,BAO_0000179,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142169,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625786,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,4.0
85945,,1829639,CHEMBL910826,Antimicrobial activity against Bifidobacterium animalis ATCC 27536,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.98
85946,,1829641,CHEMBL910827,Antimicrobial activity against Bifidobacterium bifidum R0071,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,3.9,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,3.9
85947,,1829643,CHEMBL910828,Antimicrobial activity against Bifidobacterium bifidum ATCC 15696,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,0.98
85948,,1829645,CHEMBL910829,Antimicrobial activity against Bifidobacterium bifidum BB12,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,0.98
85949,,1829647,CHEMBL910830,Antimicrobial activity against Bifidobacterium breve ATCC 15700,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,0.98
85950,,1829649,CHEMBL910831,Antimicrobial activity against Bifidobacterium infantis ATCC 15697,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.98
85951,,1829651,CHEMBL911484,Antimicrobial activity against Bifidobacterium longum ATCC 15707,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,0.98
85952,,1829653,CHEMBL910832,Antimicrobial activity against Bifidobacterium longum ATCC 15708,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,0.98
85953,,1829655,CHEMBL910833,Antimicrobial activity against Bifidobacterium longum R0175,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,3.9,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,3.9
85954,,1829657,CHEMBL910834,Antimicrobial activity against Bifidobacterium longum P/N 601377,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,0.98
85955,,1829659,CHEMBL910835,Antimicrobial activity against Bifidobacterium pseudolongum ATCC 25562,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.98
85956,,1829661,CHEMBL910836,Antimicrobial activity against Bifidobacterium thermophilum ATCC 25866,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL614752,Bifidobacterium thermophilum,Bifidobacterium thermophilum,33905.0,,MIC,ug ml-1,UO_0000274,0.98
85957,,1829663,CHEMBL910837,Antimicrobial activity against Bifidobacterium breve R0070,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,1.9,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,1.9
85958,,1829855,CHEMBL910838,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium animalis ATCC 27536 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.98
85959,,1829857,CHEMBL910839,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium bifidum R0071 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,1.9,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,1.9
85960,,1829859,CHEMBL910840,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium bifidum BB12 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,0.98
85961,,1829923,CHEMBL910841,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium breve ATCC 15700 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,0.98
85962,,1829925,CHEMBL910842,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium breve R0070 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,1.9,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,1.9
85963,,1829927,CHEMBL910843,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium infantis ATCC 15697 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.98
85964,,1829929,CHEMBL910844,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium longum ATCC 15707 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,0.98
85965,,1829931,CHEMBL910845,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium longum R0175 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,0.98
85966,,1829933,CHEMBL910846,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium longum P/N 601377 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,0.98
85967,,1829935,CHEMBL910847,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium pseudolongum ATCC 25562 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.98
85968,,1829937,CHEMBL910848,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium thermophilum ATCC 25866 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL614752,Bifidobacterium thermophilum,Bifidobacterium thermophilum,33905.0,,MIC,ug ml-1,UO_0000274,0.98
85969,,1830287,CHEMBL910849,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium animalis ATCC 27536 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.98
85970,,1830290,CHEMBL910850,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium bifidum R0071 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,0.98
85971,,1830293,CHEMBL910851,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium bifidum ATCC 15696 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,0.98
85972,,1830296,CHEMBL910852,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium bifidum BB12 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,0.98
85973,,1830299,CHEMBL910853,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium breve ATCC 15700 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,0.98
85974,,1830302,CHEMBL910854,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium breve R0070 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,0.98
85975,,1830305,CHEMBL910855,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium infantis ATCC 15697 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.98
85976,,1830308,CHEMBL910856,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium longum ATCC 15707 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,0.98
85977,,1830311,CHEMBL910857,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium longum ATCC 15708 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,0.98
85978,,1830314,CHEMBL912625,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium longum R0175 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,0.98
85979,,1830317,CHEMBL912626,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium longum P/N 601377 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,0.98
85980,,1830320,CHEMBL912627,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium pseudolongum ATCC 25562 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.98
85981,,1830323,CHEMBL912628,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium thermophilum ATCC 25866 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL614752,Bifidobacterium thermophilum,Bifidobacterium thermophilum,33905.0,,MIC,ug ml-1,UO_0000274,0.98
85982,,1830715,CHEMBL912629,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium animalis ATCC 27536 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.98
85983,,1830719,CHEMBL912630,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium bifidum R0071 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,0.98
85984,,1830724,CHEMBL912631,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium bifidum BB12 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,0.98
85985,,1830731,CHEMBL912632,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium breve ATCC 15700 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,0.98
85986,,1830736,CHEMBL912633,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium breve R0070 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,0.98
85987,,1830741,CHEMBL912634,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium longum ATCC 15707 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,0.98
85988,,1830746,CHEMBL912635,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium longum ATCC 15708 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,0.98
85989,,1830751,CHEMBL912636,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium longum R0175 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,0.98
85990,,1830756,CHEMBL912637,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium longum P/N 601377 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,0.98
85991,,1830761,CHEMBL912638,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium thermophilum ATCC 25866 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625635,=,1,1,=,MIC,ug.mL-1,0.98,CHEMBL614752,Bifidobacterium thermophilum,Bifidobacterium thermophilum,33905.0,,MIC,ug ml-1,UO_0000274,0.98
85992,,1833736,CHEMBL856438,Activity of Enterobacter cloacae S3 isolate beta lactamase LAP1 expressed in Escherichia coli DH10B,B,BAO_0000477,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142182,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/Nanomolar,625853,=,1,1,=,Km,nM,20000.0,CHEMBL612545,,Unchecked,,,Km,uM,UO_0000065,20.0
85993,,1833748,CHEMBL856437,Inhibition of Enterobacter cloacae S3 isolate beta lactamase LAP1 expressed in Escherichia coli DH10B,B,BAO_0000190,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142182,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/Nanomolar,625853,=,1,1,=,IC50,nM,80.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,0.08
85994,,1834874,CHEMBL856439,Ratio of kcat to Km of Enterobacter cloacae S3 isolate beta lactamase LAP1 expressed in Escherichia coli DH10B,B,BAO_0000179,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1142182,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,625853,=,1,0,=,Kcat/Km,/mM/s,10000.0,CHEMBL612545,,Unchecked,,,Kcat/Km,/mM/s,,10000.0
85995,,1866839,CHEMBL914118,Activity of Escherichia coli BL21(DE3) beta-lactamase TEM151,B,BAO_0000481,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146197,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,634743,=,1,0,=,Kcat,/s,251.0,CHEMBL612545,,Unchecked,,,Kcat,/s,,251.0
85996,,1866840,CHEMBL914118,Activity of Escherichia coli BL21(DE3) beta-lactamase TEM151,B,BAO_0000477,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146197,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/Nanomolar,634743,=,1,1,=,Km,nM,25000.0,CHEMBL612545,,Unchecked,,,Km,uM,UO_0000065,25.0
85997,,1866842,CHEMBL914119,Activity of Escherichia coli BL21(DE3) beta-lactamase TEM29,B,BAO_0000481,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146197,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,634743,=,1,0,=,Kcat,/s,235.0,CHEMBL612545,,Unchecked,,,Kcat,/s,,235.0
85998,,1866843,CHEMBL914119,Activity of Escherichia coli BL21(DE3) beta-lactamase TEM29,B,BAO_0000477,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146197,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,http://www.openphacts.org/units/Nanomolar,634743,=,1,1,=,Km,nM,12000.0,CHEMBL612545,,Unchecked,,,Km,uM,UO_0000065,12.0
85999,,1866844,CHEMBL914120,Activity of Escherichia coli BL21(DE3) beta-lactamase TEM152,B,BAO_0000481,BAO_0000019,assay format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,CHEMBL1146197,Antimicrob Agents Chemother,2007.0,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,0,,634743,=,1,0,=,Kcat,/s,196.0,CHEMBL612545,,Unchecked,,,Kcat,/s,,196.0
